slno-10q_20190331.htm

0001564590-19-018686.txt : 20190513 0001564590-19-018686.hdr.sgml : 20190513 20190513090207 ACCESSION NUMBER: 0001564590-19-018686 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 56 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20190513 DATE AS OF CHANGE: 20190513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOLENO THERAPEUTICS INC CENTRAL INDEX KEY: 0001484565 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 770523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36593 FILM NUMBER: 19817011 BUSINESS ADDRESS: STREET 1: 1235 RADIO ROAD STREET 2: SUITE 110 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 650-213-8444 MAIL ADDRESS: STREET 1: 1235 RADIO ROAD STREET 2: SUITE 110 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: Capnia, Inc. DATE OF NAME CHANGE: 20100219 10-Q 1 slno-10q_20190331.htm 10-Q slno-10q_20190331.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2019

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-36593

SOLENO THERAPEUTICS, INC.

(Exact name of registrant as specified in its charter)

Delaware

77-0523891

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

1235 Radio Road, Suite 110,

Redwood City, California

(Address of principal executive offices)

94065

(Zip Code)

(650) 213-8444

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.001 par value	SLNO	NASDAQ
Common Stock, $0.001 per value, underlying the warrants	SLNOW	NASDAQ

As of May 6, 2019, there were 31,776,584 shares of the registrant’s Common Stock, par value $0.001 per share, outstanding.

SOLENO THERAPEUTICS, INC.

TABLE OF CONTENTS

	Page
PART I—FINANCIAL INFORMATION	3
Item 1. Financial Statements	3
Condensed Consolidated Balance Sheets	3
Condensed Consolidated Statements of Operations (unaudited)	4
Condensed Consolidated Statements of Stockholders’ Equity (unaudited)	5
Condensed Consolidated Statements of Cash Flows (unaudited)	6
Notes to Condensed Consolidated Financial Statements (unaudited)	7
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	20
Item 3. Quantitative and Qualitative Disclosures About Market Risk	24
Item 4. Controls and Procedures	24
PART II—OTHER INFORMATION	26
Item 1. Legal Proceedings	26
Item 1A. Risk Factors	26
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	26
Item 3. Defaults Upon Senior Securities	26
Item 4. Mine Safety Disclosures	26
Item 5. Other Information	26
Item 6. Exhibits	26
EXHIBIT INDEX	27
SIGNATURES	33

PART I—FINANCIAL INFORMATION

Item 1.

Financial Statements

Soleno Therapeutics, Inc.

Condensed Consolidated Balance Sheets

(In thousands except share and per share data)

	March 31, 2019			December 31, 2018
Assets	(Unaudited)
Current assets
Cash and cash equivalents	$	19,402		$	23,099
Prepaid expenses and other current assets		603			529
Due from related party		72			64
Minority interest investment in former subsidiary		788			978
Total current assets		20,865			24,670
Long-term assets
Property and equipment, net		19			12
Intangible assets, net		17,983			18,469
Total assets	$	38,867		$	43,151
Liabilities and stockholders’ equity
Current liabilities
Accounts payable	$	1,258		$	934
Accrued compensation and other current liabilities		992			943
Total current liabilities		2,250			1,877
Long-term liabilities
Series A warrant liability		73			49
2017 PIPE Warrant liability		6,274			4,563
2018 PIPE Warrant liability		784			600
Contingent liability for Essentialis purchase price		5,855			5,649
Total liabilities		15,236			12,738
Commitments and contingencies (Note 6)
Stockholders’ equity
Preferred Stock, $.001 par value, 10,000,000 shares authorized:
Series B convertible preferred stock, 13,780 shares designated at March 31, 2019 and December 31, 2018; zero shares issued and outstanding at March 31, 2019 and at December 31, 2018. Liquidation value of zero.		—			—
Common stock, $0.001 par value, 100,000,000 shares authorized, 31,776,584 and 31,755,169 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively.		32			32
Additional paid-in-capital		157,661			157,413
Accumulated deficit		(134,062	)		(127,032	)
Total stockholders’ equity		23,631			30,413
Total liabilities and stockholders’ equity	$	38,867		$	43,151

See accompanying notes to condensed consolidated financial statements

Soleno Therapeutics, Inc.

Condensed Consolidated Statements of Operations

(unaudited)

(In thousands except share and per share data)

	Three Months Ended March 31,
	2019			2018
Operating expenses
Research and development	$	2,760		$	1,180
General and administrative		2,012			1,867
Change in fair value of contingent consideration		206			428
Total operating expenses		4,978			3,475
Operating loss		(4,978	)		(3,475	)
Other income (expense)
Cease-use income		—			3
Change in fair value of warrants liabilities		(1,919	)		163
Loss from minority interest investment		(190	)		—
Interest income		57			19
Total other income (expense)		(2,052	)		185
Loss from continuing operations		(7,030	)		(3,290	)
Loss from discontinued operations		—			(514	)
Net loss	$	(7,030	)	$	(3,804	)
Loss per common share from continuing operations, basic and diluted	$	(0.22	)	$	(0.17	)
Loss per common share from discontinued operations, basic and diluted		—			(0.02	)
Net loss per common share, basic and diluted	$	(0.22	)	$	(0.19	)
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share		31,756,120			19,530,311

See accompanying notes to condensed consolidated financial statements

Soleno Therapeutics, Inc.

Condensed Consolidated Statements of Stockholders’ Equity

(unaudited)

(In thousands except share data)

	Series B Convertible Preferred Stock						Common Stock				Additional Paid-In			Accumulated			Total Stockholders’
	Shares			Amount			Shares		Amount		Capital			Deficit			Equity
Balances at December 31, 2017		4,571		$	—			19,238,972	$	19	$	140,495		$	(113,697	)	$	26,817
Stock-based compensation												200						200
Issuance of common stock on conversion of series B convertible preferred shares		(1,000	)		(—	)		200,000		1		—						1
Issuance of restricted common stock for bonuses								99,217		—		159						159
Issuance of common stock to board members in lieu of cash payments for quarterly board fees								49,519		—		82						82
Transaction costs for the 2017 PIPE common stock and warrant issuance.												(203	)					(203	)
Issuance of common stock held back on acquisition of Essentialis								180,667		—		—						—
Net loss															(3,804	)		(3,804	)
Balances at March 31, 2018		3,571		$	—			19,768,375	$	20	$	140,733		$	(117,501	)	$	23,252




	Series B Convertible Preferred Stock						Common Stock				Additional Paid-In			Accumulated			Total Stockholders’
	Shares			Amount			Shares		Amount		Capital			Deficit			Equity
Balances at December 31, 2018		-		$	—			31,755,169	$	32	$	157,413		$	(127,032	)	$	30,413
Stock-based compensation												202						202
Issuance of common stock to board members in lieu of cash payments for quarterly board fees								21,415		—		46						46
Net loss															(7,030	)		(7,030	)
Balances at March 31, 2019		—		$	—			31,776,584	$	32	$	157,661		$	(134,062	)	$	23,631

See accompanying notes to condensed consolidated financial statements

Soleno Therapeutics, Inc.

Condensed Consolidated Statements of Cash Flows

(unaudited)

(In thousands)

	Three Months Ended March 31,
	2019			2018
Cash flows from operating activities:
Net loss	$	(7,030	)	$	(3,804	)
Loss from discontinued operations		—			(514	)
Loss from continuing operations		(7,030	)		(3,290	)
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities:
Depreciation and amortization		489			492
Stock-based compensation expense		202			341
Board fees paid with common stock		46			82
Change in fair value of stock warrants		1,919			(163	)
Change in fair value of contingent consideration		206			428
Operating loss on minority interest investment		190			—
Change in operating assets and liabilities:
Prepaid expenses and other current assets		(74	)		(80	)
Due from related party		(8	)		—
Accounts payable		324			409
Accrued compensation and other current liabilities		49			(252	)
Net cash used in continuing operating activities		(3,687	)		(2,033	)
Net cash used in discontinued operating activities		—			(487	)
Net cash used in operating activities		(3,687	)		(2,520	)
Cash flows from investing activities:
Purchases of property and equipment		(10	)		—
Net cash used in continuing investing activities		(10	)		—
Net cash used in investing activities		(10	)		—
Cash flows from financing activities:
Cash paid for the issuance of common stock and common stock warrants		—			(112	)
Net cash used in continuing financing activities		—			(112	)
Net cash provided by discontinued financing activities		—			400
Net cash provided by financing activities		—			288
Net decrease in cash, cash equivalents and restricted cash from continuing operations		(3,697	)		(2,145	)
Net decrease in cash, cash equivalents and restricted cash from discontinued operations		—			(87	)
Net decrease in cash, cash equivalents and restricted cash		(3,697	)		(2,232	)
Net increase in cash and cash equivalents included in current assets held for sale		—			(2	)
Cash, cash equivalents and restricted cash, beginning of period		23,099			17,135
Cash, cash equivalents and restricted cash, end of period	$	19,402		$	14,901
Supplemental disclosures of non-cash investing and financing information
Accrued liability for cost of issuing common stock	$	—		$	91

See accompanying notes to condensed consolidated financial statements.

Soleno Therapeutics, Inc.

March 31, 2019

Notes to Condensed Consolidated Financial Statements

(unaudited)

Note 1. Overview

Soleno Therapeutics, Inc. (the “Company” or “Soleno”) was incorporated in the State of Delaware on August 25, 1999, and is located in Redwood City, California. On May 8, 2017, Soleno received stockholder approval to amend its Amended and Restated Certificate of Incorporation to change its name from “Capnia, Inc.” to “Soleno Therapeutics, Inc.” The Company was initially established as a diversified healthcare company that developed and commercialized innovative diagnostics, devices and therapeutics addressing unmet medical needs, which consisted of: precision metering of gas flow technology marketed as Serenz ^® Allergy Relief, or Serenz; CoSense ^® End-Tidal Carbon Monoxide (ETCO) Monitor, or CoSense, which measures ETCO and aids in the detection of excessive hemolysis, a condition in which red blood cells degrade rapidly and which can lead to adverse neurological outcomes; and, products that included temperature probes, scales, surgical tables, and patient surfaces.

The Company’s previously wholly-owned subsidiary, NeoForce, Inc., or NFI, through which the Company acquired substantially all of the assets of an unrelated privately-held company, NeoForce Group, Inc., or NeoForce, also marketed innovative pulmonary resuscitation solutions for the inpatient and ambulatory neonatal markets.

The Company acquired Essentialis, Inc., or Essentialis, through a merger, or the Merger, on March 7, 2017, pursuant to Agreement and Plan of Merger dated December 22, 2016. Essentialis’s efforts prior to the Merger were focused primarily on developing and testing product candidates that target the ATP-sensitive potassium channel, a metabolically regulated membrane protein whose modulation has the potential to impact a wide range of rare metabolic, cardiovascular, and CNS diseases. Essentialis has tested Diazoxide Choline Controlled Release Tablet, or DCCR, as a treatment for Prader-Willi Syndrome, or PWS, a complex metabolic/neurobehavioral disorder. DCCR has orphan designation for the treatment of PWS in the United States, or U.S., as well as in the European Union, or E.U. Consummation of the Merger was subject to various closing conditions, including the Company’s consummation of a financing of at least $8.0 million at, or substantially contemporaneous with, the closing of the Merger, which occurred on March 7, 2017 and the receipt of stockholder approval of the Merger at a special meeting of its stockholders, which was held on March 6, 2017.

Subsequent to the acquisition of Essentialis, the Company determined to divest, sell or otherwise dispose of the CoSense, NFI and Serenz businesses. Accordingly, and pursuant to ASC 205-20-45-10, any assets and liabilities related to the discontinued activities of CoSense, NFI and Serenz have been presented separately in the balance sheet as held for sale items, and the related operations reported herein for the CoSense, NFI and Serenz activities are reported as discontinued operations in the statements of operations.

The Company determined to divest, sell or otherwise dispose of the CoSense, NFI and Serenz businesses in order to focus on the development and commercialization of novel therapeutics for the treatment of rare diseases. The Company’s current research and development efforts are primarily focused on advancing its lead candidate, DCCR tablets for the treatment of PWS, into late-stage clinical development.

The Company sold its entire interest in NFI in a stock transaction that was completed on July 18, 2017, pursuant to a Stock Purchase Agreement dated July 18, 2017, or the NFI Purchase Agreement, entered into with Neoforce Holdings, Inc., a wholly-owned subsidiary of Flexicare Medical Limited, a privately-held United Kingdom company, for $720,000 and adjustments for inventory and the current cash balances held at NFI.

On December 4, 2017, Soleno, and Capnia, Inc., a Delaware corporation, or Capnia, entered into a joint venture with OptAsia Healthcare Limited, or OAHL. The purpose of the joint venture is to develop and commercialize medical monitors, including CoSense, that measure end-tidal carbon monoxide in breath to assist in the detection of excessive hemolysis in neonates, a condition in which red blood cells degrade rapidly and which can lead to adverse neurological outcomes.

The Company has previously charged to expense all previously-held assets related to its Serenz operations, and there are no remaining Serenz assets, liabilities or operations related to the Company’s previous Serenz-related business.

Note 2. Going Concern and Management’s Plans

The Company had a net loss of $7.0 million during the three months ended March 31, 2019 and has an accumulated deficit of $134.1 million at March 31, 2019 resulting from having incurred losses since its inception. The Company had $18.6 million of working capital at March 31, 2019 and used $3.7 million of cash in its operating activities during the three months ended March 31, 2019. The Company has financed its operations principally through issuances of equity securities.

On December 19, 2018, the Company entered into a Securities Purchase Agreement with certain purchasers, pursuant to which the Company sold and issued 10,272,375 units at a price per unit of $1.61, for aggregate gross proceeds of $16.5 million. Each unit consisted of one share of common stock and a warrant to purchase 0.05 shares of common stock at an exercise price of $2.00 per share, for an aggregate of 10,272,375 shares of common stock and corresponding warrants to purchase an aggregate of 513,617 shares of common stock, together with the shares of common stock are referred to as the 2018 Resale Shares.

The accompanying condensed consolidated financial statements have been prepared under the assumption the Company will continue to operate as a going concern, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. The condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts of liabilities that may result from uncertainty related to the Company’s ability to continue as a going concern.

The Company expects to continue incurring losses for the foreseeable future and may be required to raise additional capital to complete its clinical trials, pursue product development initiatives and penetrate markets for the sale of its products. Management believes that the Company will continue to have access to capital resources through possible public or private equity offerings, debt financings, corporate collaborations or other means, but the Company’s access to such capital resources is uncertain and is not assured. If the Company is unable to secure additional capital, it may be required to curtail its clinical trials and development of new products and take additional measures to reduce expenses in order to conserve its cash in amounts sufficient to sustain operations and meet its obligations. These measures could cause significant delays in the Company’s efforts to complete its clinical trials and commercialize its products, which is critical to the realization of its business plan and the future operations of the Company. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of asset amounts or the classification of liabilities that might be necessary should it be unable to continue as a going concern.

Management believes that the Company does not have sufficient capital resources to sustain operations through at least the next twelve months from the date of this filing. Additionally, in view of the Company’s expectation to incur significant losses for the foreseeable future it will be required to raise additional capital resources in order to fund its operations, although the availability of, and the Company’s access to such resources is not assured. Accordingly, management believes that there is substantial doubt regarding the Company’s ability to continue operating as a going concern within one year from the date of filing these financial statements.

Note 3. Summary of Significant Accounting Policies

There have been no material changes to the significant accounting policies during the three months ended March 31, 2019 as compared to the significant accounting policies described in Note 3 of the “Notes to Consolidated Financial Statements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. Below are those policies with current period updates.

Basis of Presentation

The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP, and the applicable rules and regulations of the SEC for interim financial information. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. The condensed consolidated balance sheet at December 31, 2018, has been derived from the audited consolidated financial statements at that date, but does not include all disclosures, including notes, required by GAAP for complete financial statements.

The unaudited interim condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, reflect all adjustments of a normal recurring nature that are necessary for a fair presentation of the results for the interim periods presented. The interim results are not necessarily indicative of the results for any future interim period or for the entire year.

The accompanying condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the related notes thereto for the year ended December 31, 2018, included in the Company’s Annual Report on Form 10-K.

Recent Accounting Standards

Recently Adopted Accounting Standards

with the accounting for share-based payments to employees, with certain exceptions. Under the guidance, the measurement of equity-classified nonemployee awards is fixed at the grant date, which may lower the cost and reduce volatility in the income statement. This ASU was early adopted by the Company at the beginning of 2019. Its adoption did not have a material impact on the Company’s condensed consolidated financial statements.

In August 2018, SEC adopted the final rule under SEC Release No. 33-10532, “Disclosure Update and Simplification”, amending certain disclosure requirements that were redundant, duplicative, overlapping, outdated or superseded. In addition, the amendments expanded the disclosure requirements on the analysis of stockholders’ equity for interim financial statements. Under the amendments, an analysis of changes in each caption of stockholders’ equity presented in the balance sheet must now be provided in a note or separate statement. The Company has applied this new guidance to its condensed financial statements for the first quarter of 2019.

Recently Issued Accounting Standards

In February 2016, the FASB issued ASU 2016-02: “Leases (Topic 842)”. ASU 2016-02 provides new comprehensive lease accounting guidance that supersedes existing lease guidance. Upon adoption of ASU 2016-02, the Company may elect to apply the transition approach either as of the beginning of the earliest period presented in the financial statements – in which case it would restate its comparative periods, or as of the beginning of the period of adoption – in which case it would not restate its comparative periods. ASU 2016-02 requires the Company to capitalize most current operating lease obligations as right-of-use assets with a corresponding liability based on the present value of future operating lease obligations. Criteria for distinguishing leases between finance and operating are substantially similar to criteria for distinguishing between capital leases and operating leases in existing lease guidance. Lease agreements that are 12 months or less are permitted to be excluded from the balance sheet. Topic 842 includes a number of optional practical expedients that the Company may elect to apply. Expanded disclosures with additional qualitative and quantitative information will also be required. The adoption will include updates as provided under ASU 2018-01, Leases (Topic 842): Land Easement Practical Expedient for Transition to Topic 842, ASU 2018-10, Codification Improvements to Topic 842, Leases, ASU 2018-20, Leases (Topic 842): Narrow-Scope Improvements for Lessors and ASU 2019-01, Leases (Topic 842): Codification Improvements. Topic 842 is effective for public entities with fiscal years beginning after December 15, 2018 and for all other entities for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. As the Company is an emerging growth company and elected to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act, Topic 842 will be effective for the Company beginning in fiscal 2020, although early adoption is permitted. The Company is currently evaluating the potential impact of adoption of this standard on its condensed consolidated financial statements and the additional transition method under ASU 2018-11, which allows the Company to recognize Topic 842’s cumulative effect within retained earnings in the period of adoption.

In July 2017, the FASB issued ASU 2017-11, “Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features; (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception”, (ASU 2017-11). Part I of this update addresses the complexity of accounting for certain financial instruments with down round features. Down round features are features of certain equity-linked instruments (or embedded features) that result in the strike price being reduced on the basis of the pricing of future equity offerings. Current accounting guidance creates cost and complexity for entities that issue financial instruments (such as warrants and convertible instruments) with down round features that require fair value measurement of the entire instrument or conversion option. Part II of this update addresses the difficulty of navigating Topic 480, Distinguishing Liabilities from Equity, because of the existence of extensive pending content in the FASB Accounting Standards Codification. This pending content is the result of the indefinite deferral of accounting requirements about mandatorily redeemable financial instruments of certain nonpublic entities and certain mandatorily redeemable noncontrolling interests. The amendments in Part II of this update do not have an accounting effect. The amendments in Part I of ASU 2017-11 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other entities, the amendments in Part I are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. As the Company is an emerging growth company and elected to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act, this ASU 2017-11 will be effective for the Company beginning in fiscal 2020, although early adoption is permitted. The Company is currently assessing the potential impact of adopting ASU 2017-11 on its condensed consolidated financial statements and related disclosures.

No. 2018-13 and delay adoption of the additional disclosures until their effective date. The Company has not yet evaluated the impact of adoption of this ASU on its condensed consolidated financial statements disclosures.

Note 4. Fair Value of Financial Instruments

The carrying value of the Company’s cash, restricted cash, cash equivalents and accounts payable, approximate fair value due to the short-term nature of these items.

Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.

The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:

•

Level I — Unadjusted quoted prices in active markets for identical assets or liabilities;

•

Level II — Inputs other than quoted prices included within Level I that are observable, unadjusted quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and

•

Level III — Unobservable inputs that are supported by little or no market activity for the related assets or liabilities.

The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands).

	Fair Value Measurements at March 31, 2019
	Total		Level 1		Level 2		Level 3
Liabilities
Series A warrant liability	$	73	$	73	$	—	$	—
Series C warrant liability		—		—		—		—
2017 PIPE warrant liability		6,274		—		—		6,274
2018 PIPE warrant liability		784		—		—		784
Essentialis purchase price contingency liability		5,855		—		—		5,855
Total common stock warrant and contingent consideration liability	$	12,986	$	73	$	—	$	12,913

	Fair Value Measurements at December 31, 2018
	Total		Level 1		Level 2		Level 3
Liabilities
Series A warrant liability	$	49	$	49	$	—	$	—
Series C warrant liability		—		—		—		—
2017 PIPE warrant liability		4,563		—		—		4,563
2018 PIPE warrant liability		600		—		—		600
Essentialis purchase price contingency liability		5,649		—		—		5,649
Total common stock warrant and contingent consideration liability	$	10,861	$	49	$	—	$	10,812

Monte Carlo simulation of a geometric Brownian motion model. The Monte Carlo simulation pricing model requires the input of highly subjective assumptions including the expected stock price volatility, the expected term, the expected dividend yield and the risk-free interest rate. The fair value of the Essentialis purchase price contingent liability is estimated using scenario-based methods based upon the Company’s analysis of the likelihood of obtaining specified approvals from the Federal Drug Administration as well as reaching cumulative revenue milestones (see Note 10). The Level 3 estimates are based, in part, on subjective assumptions.

During the periods presented, the Company has not changed the manner in which it values liabilities that are measured at fair value using Level 3 inputs. The Company recognizes transfers between levels of the fair value hierarchy as of the end of the reporting period. There were no transfers within the hierarchy during the periods presented.

The following table sets forth a summary of the changes in the fair value of the Company’s Level 1 and Level 3 warrants, which are treated as liabilities (dollars in thousands).

	Series A Warrant				Series C Warrant				2017 PIPE Warrants				2018 PIPE Warrants				Purchase Price
	Number of Warrants		Liability		Number of Warrants		Liability		Number of Warrants		Liability		Number of Warrants		Liability		Contingent Liability
Balance at December 31, 2018		485,121	$	49		118,083	$	—		6,024,425	$	4,563		513,617	$	600	$	5,649
Change in value of Series A Warrants		—		24		—		—		—		—		—		—		—
Change in value of 2017 PIPE Warrants		—		—		—		—		—		1,711		—		—		—
Change in value of 2018 PIPE Warrants		—		—		—		—		—		—		—		184		—
Change in value of contingent liability		—		—		—		—		—		—		—		—		206
Balance at March 31, 2019		485,121	$	73		118,083	$	—		6,024,425	$	6,274		513,617	$	784	$	5,855

Note 5. Warrant Liabilities

The Company has issued multiple warrant series, of which the Series A Warrants, Series C Warrants, the 2017 PIPE Warrants and the 2018 PIPE Warrants (the “Warrants”) are considered liabilities pursuant to the guidance established by ASC 815 Derivatives and Hedging.

Accounting Treatment

The Company accounts for the Warrants in accordance with the guidance in ASC 815. As indicated below, the Company may be obligated to settle Warrants in cash in the case of a Fundamental Transaction (as defined in the Warrants).

The Company classified the Warrants, with a term greater than one year, as long-term liabilities at their fair value and will re-measure the warrants at each balance sheet date until they are exercised or expire. Any change in the fair value is recognized as other income (expense) in the Company’s condensed consolidated statements of operations.

Series A Warrants

The Company has issued 489,921 Series A Warrants to purchase shares of its common stock at an exercise price of $32.50 per share in connection with the unit offering offered in the Company’s initial public offering, or the IPO, in November 2014. The Series A Warrants are exercisable at any time prior to the expiration of the five-year term on November 12, 2019.

Upon the completion of the IPO, the Series A Warrants started trading on the NASDAQ under the symbol SLNOW. As the Series A Warrants are publicly traded, the Company uses the closing price on the measurement date to determine the fair value of the Series A Warrants. The Series A Warrants contract further provides for the payment of liquidated damages at an amount per month equal to 1% of the aggregate volume weighted average price, or VWAP, of the shares into which each Warrant is convertible in the event that the Company is unable to maintain the effectiveness of a registration statement as described herein. The Company evaluated the registration payment arrangement stipulated in the terms of these securities and determined that it is probable that the Company will maintain an effective registration statement and has therefore not allocated any portion of the proceeds related to the warrant financings to the registration payment arrangement. The Warrants also contain a fundamental transactions provision that permits their settlement in cash at fair value at the option of the holder upon the occurrence of a change in control. Such change in control events include tender offers or hostile takeovers, which are not within the sole control of the Company as the issuer of these warrants. Accordingly, the Warrants are considered to have a cash settlement feature that precludes their classification as equity instruments. Settlement at fair value upon the occurrence of a fundamental transaction would be computed using the Black Scholes Option Pricing Model, which approximates the binomial lattice model.

Since their issuance, a total of 4,800 Series A Warrants have been exercised. As of March 31, 2019, the fair value of the 485,121 outstanding Series A Warrants was approximately $73,000 and the increase of approximately $24,000 in fair value during the three months ended March 31, 2019 was recorded as other income (expense) in the condensed consolidated statements of operations.

Series C Warrants

On March 5, 2015, the Company entered into separate agreements with certain Series B Warrant holders, who agreed to exercise their Series B Warrants to purchase an aggregate of 117,902 shares of the Company’s common stock at an exercise price of $32.50 per share, resulting in the de-recognition of $6.7 million of the previously issued Series B Warrant liability and gross proceeds to the Company of $3.8 million based on the exercise price of the Series B Warrants. In connection with this exercise of the Series B Warrants, the Company issued to each investor who exercised Series B Warrants, new Series C Warrants for the number of shares of the Company’s common stock underlying the Series B Warrants that were exercised. Each Series C Warrant is exercisable at $31.25 per share and will expire on March 5, 2020. The Series C Warrants contract further provides for the payment of liquidated damages at an amount per month equal to 1% of the aggregate volume weighted average price, or VWAP, of the shares into which each Warrant is convertible in the event that the Company is unable to maintain the effectiveness of a registration statement as described herein. The Company evaluated the registration payment arrangement stipulated in the terms of these securities and determined that it is probable that the Company will maintain an effective registration statement and has therefore not allocated any portion of the proceeds related to the warrant financings to the registration payment arrangement. The Warrants also contain a fundamental transactions provision that permits their settlement in cash at fair value at the option of the holder upon the occurrence of a change in control. Such change in control events include tender offers or hostile takeovers, which are not within the sole control of the Company as the issuer of these warrants. Accordingly, the Warrants are considered to have a cash settlement feature that precludes their classification as equity instruments. Settlement at fair value upon the occurrence of a fundamental transaction would be computed using the Black Scholes Option Pricing Model, which approximates the binomial lattice model.

In April 2015, the Company issued a tender offer to the remaining holders of Series B Warrants to induce the holders to cash exercise the outstanding Series B Warrants in exchange for new Series C Warrants with an exercise price of $31.25 per share that expire on March 5, 2020. The tender offer was extended to Series B Warrant holders under a registration statement filed with the SEC on Form S-4, which was declared effective on June 25, 2015 and expired on July 24, 2015. During July 2015, certain Series B Warrant holders tendered their Series B Warrants under the tender offer, which resulted in the issuance of 181 shares of the Company’s common stock, the issuance of 181 Series C Warrants and proceeds to the Company of approximately $6,000.

The Series C Warrants are exercisable into 118,083 shares of the Company’s common stock. As of March 31, 2019, the fair value of the Series C Warrants was determined to be zero, consistent with the balance as of December 31, 2018.

The Company has calculated the fair value of the Series C Warrants using a Black-Scholes pricing model. The Black-Scholes pricing model requires the input of highly subjective assumptions including the expected stock price volatility. The Company used the following inputs.

	March 31, 2019			December 31, 2018
Volatility		90	%		90	%
Contractual term (years)		0.92			1.17
Expected dividend yield		—	%		—	%
Risk-free rate		2.41	%		2.60	%

Warrants Issued as Part of the Units in the 2017 PIPE Offering

The 2017 PIPE Warrants were issued on December 15, 2017 in the 2017 PIPE Offering, pursuant to a Warrant Agreement with each of the investors in the 2017 PIPE Offering, and entitle the holder to purchase one share of the Company’s common stock at an exercise price equal to $2.00 per share, subject to adjustment as discussed below, at any time commencing upon issuance of the 2017 PIPE Warrants and terminating at the earlier of December 15, 2020 or 30 days following positive Phase III results for the DCCR tablet in PWS.

The exercise price and number of shares of common stock issuable upon exercise of the 2017 PIPE Warrants may be adjusted in certain circumstances, including the event of a stock split, stock dividend, extraordinary dividend, or recapitalization, reorganization, merger or consolidation. However, the exercise price of the 2017 PIPE Warrants will not be reduced below $1.72.

In the event of a change of control of the Company, the holders of unexercised warrants may present their unexercised warrants to the Company, or its successor, to be purchased by the Company, or its successor, in an amount equal to the per share value determined by the Black Scholes methodology.

As of March 31, 2019, the fair value of the 2017 PIPE Warrants was estimated at $6.3 million. The increase in the fair value of the liability for the 2017 PIPE Warrants of approximately $1.7 million during the three months ended March 31, 2019 was recorded as other income (expense) in the condensed consolidated statements of operations.

The Company has calculated the fair value of the 2017 PIPE Warrants using a Monte Carlo simulation of a geometric Brownian motion model. The Monte Carlo simulation pricing model requires the input of highly subjective assumptions including the expected stock price volatility. The following summarizes certain key assumptions used in estimating the fair values.

	March 31, 2019			December 31, 2018
Volatility		86	%		75	%
Contractual term (years)		1.7			2.0
Expected dividend yield		—	%		—	%
Risk-free rate		2.40	%		2.51	%

Warrants Issued as Part of the Units in the 2018 PIPE Offering

The 2018 PIPE Warrants were issued on December 19, 2018 in the 2018 PIPE Offering, pursuant to a Warrant Agreement with each of the investors in the 2018 PIPE Offering, and entitle the holders of each of the 10,272,375 units to purchase 0.05 shares of the Company’s common stock at an exercise price equal to $2.00 per share, subject to adjustment as discussed below, at any time commencing upon issuance of the 2018 PIPE Warrants and terminating on December 21, 2023.

The exercise price and number of shares of common stock issuable upon exercise of the 2018 PIPE Warrants may be adjusted in certain circumstances, including the event of a stock split, stock dividend, extraordinary dividend, or recapitalization, reorganization, merger or consolidation. However, the exercise price of the 2018 PIPE Warrants will not be reduced below $2.00.

As of March 31, 2019, the fair value of the 2018 PIPE Warrants was estimated at approximately $784,000. The approximate $184,000 increase in the fair value of the liability for the 2018 PIPE Warrants during the three months ended March 31, 2019 was recorded as other income (expense) in the condensed consolidated statements of operations.

The Company has calculated the fair value of the 2018 PIPE Warrants using a Monte Carlo simulation of a geometric Brownian motion model. The Monte Carlo simulation pricing model requires the input of highly subjective assumptions including the expected stock price volatility. The following summarizes certain key assumptions used in estimating the fair values.

	March 31, 2019			December 31, 2018
Volatility		86	%		75	%
Contractual term (years)		4.7			5.0
Expected dividend yield		—	%		—	%
Risk-free rate		2.23	%		2.51	%

The Monte Carlo simulation of a geometric Brownian motion model requires the use of highly subjective assumptions to estimate the fair value of stock-based awards. These assumptions include the following estimates.

•

Volatility: The Company calculates the estimated volatility rate based on the volatilities of common stock of comparable companies in its industry.

•

Contractual term: The expected life of the warrants, which is based on the contractual term of the warrants.

•

Expected dividend yield: The Company has never declared or paid any cash dividends and does not currently plan to pay cash dividends in the foreseeable future. Consequently, the Company used an expected dividend yield of zero.

•

Risk-free rate: The risk-free interest rate is based on the U.S. Treasury rate for similar periods as those of expected volatility.

Note 6. Commitments and Contingencies

Facility Leases

On July 1, 2015, the Company executed a new four-year non-cancelable operating lease agreement for 8,171 square feet of office space for its headquarters facility. The lease agreement provides for monthly lease payments of $23,300 beginning in September of 2015, with increases in the following three years. An additional 5,265 square feet of office space became part of the new lease agreement on March 1, 2016, and in December 2017 the Company subleased this additional space to a third party through the end of the lease term.

Rent expense was approximately $54,000 and $85,000 during the three months ended March 31, 2019 and 2018, respectively, net of sublease income of approximately $65,000 and $98,000, respectively.

Contingencies

In the normal course of business, the Company enters into contracts and agreements that contain a variety of representations and warranties and provide for general indemnifications. The Company’s exposure under these agreements is unknown because it involves claims that may be made against the Company in the future but have not yet been made. The Company accrues a liability for such matters when it is probable that future expenditures will be made, and such expenditures can be reasonably estimated.

Note 7. CoSense Joint Venture Agreement and Discontinued Operations

In December 2017, the Company entered into a joint venture with OAHL with respect to its CoSense product by agreeing to sell shares of Capnia, its wholly-owned subsidiary, to OAHL. CoSense was Soleno’s first Sensalyze Technology Platform product to receive 510(k) clearances from the FDA and CE Mark certification. CoSense measures CO, which can be elevated due to endogenous causes such as excessive breakdown of red blood cells, or hemolysis, or exogenous causes such as CO poisoning and smoke inhalation. The first target market for CoSense is for the use of ETCO measurements to aid in detection of hemolysis in neonates, a disorder in which CO and bilirubin are produced in excess as byproducts of the breakdown of red blood cells. The Company’s entry into the joint venture results from a comprehensive review of strategic alternatives for its legacy products and product candidates following its transition to a primarily therapeutic drug product company. The terms of the Joint Venture Agreement provide that OAHL will invest up to a total of $2.2 million in Capnia’s common shares on an incremental quarterly basis commencing in December 2017. Going forward, OAHL will be responsible for funding a portion of the Capnia operations. The Joint Venture Agreement provided that Capnia would issue shares of common shares to OAHL based on a negotiated price of $1.00 per share when the cumulative investment made by OAHL equaled or exceeded $1.2 million. For financial reporting purposes, Capnia’s assets, liabilities and results of operations had historically been consolidated with those of the Company.

During October 2018, the Company and OAHL determined and agreed that the cumulative investment made by OAHL exceeded $1.2 million during the quarter ended September 30, 2018. Accordingly, on October 16, 2018, Capnia issued 1,690,322 shares of its common stock to OAHL, representing 53% of its outstanding shares. After the share issuance the Company no longer held a controlling interest in Capnia and resulted in the deconsolidation of Capnia’s financial statements with those of the Company and a $2.0 million gain was recognized in the fourth quarter of 2018 as a result of the deconsolidation. Of this amount, $1.2 million related to the remeasurement of the Company's retained interest in the joint venture to fair value which was measured based on the negotiated price of $1.00 per share for Soleno’s remaining ownership of 1,480,000 shares less a 23% discount for lack of control over Capnia. The total gain was included in other income from continuing operations on the Company's consolidated statements of operations. The remaining 47% investment in Capnia is classified as an equity method investment and presented as a Minority interest investment in former subsidiary in the condensed consolidated balance sheet. The balance of Minority interest investment in former subsidiary decreased by approximately $190,000 during the three months ended March 31, 2019 as a result of the Company recording its share of Capnia’s net losses during the period, which is included in the line titled loss from minority interest investment in the Company’s condensed consolidated statements of operations.

There were no assets or liabilities held for sale as of March 31, 2019 or December 31, 2018 after the deconsolidation of Capnia in October 2018, and no discontinued operations during the three months ended March 31, 2019. The components of the Statements of Operations presented as Discontinued Operations during the three months ended March 31, 2018 follow (in thousands).


Product revenue	$	51
Cost of product revenue		51
Gross profit (loss)		—
Expenses
Research and development		401
Sales and marketing		11
General and administrative		102
Total expenses		514
Net loss from discontinued operations	$	(514	)

Stock-based compensation expense of approximately $19,000 was classified in discontinued operations for the three months ended March 31, 2018. There were no discontinued operations during the three months ended March 31, 2019.

Note 8. Stockholders’ Equity

Equity Incentive Plans

The Company has adopted the 1999 Incentive Stock Plan, the 2010 Equity Incentive Plan, and the 2014 Equity Incentive Plan, or the 2014 Plan, and together, the Plans. The 1999 Incentive Stock Plan expired in 2009, and the 2010 Equity Incentive Plan has been closed to new issuances. Under the 2014 Plan the Company may grant stock options, stock appreciation rights, restricted stock, restricted stock units, performance units or performance shares to employees, directors, advisors, and consultants. Options granted under the 2014 Plan may be incentive stock options (“ISOs”) or nonqualified stock options (“NSOs”). ISOs may be granted only to Company employees, including officers and directors.

The Board of Directors has the authority to determine to whom stock options will be granted, the number of options, the term, and the exercise price. Options are to be granted at an exercise price not less than fair value. For individuals holding more than 10% of the voting rights of all classes of stock, the exercise price of an option will not be less than 110% of fair value. The vesting period is normally monthly over a period of 4 years from the vesting date. The contractual term of an option is no longer than five years for ISOs for which the grantee owns greater than 10% of the voting power of all classes of stock and no longer than ten years for all other options. The terms and conditions governing restricted stock units is at the sole discretion of the Board. As of March 31, 2019, a total of 925,749 shares are available for future grant under the 2014 Plan.

The Company recognized stock-based compensation expense related to options and restricted stock units granted to employees, directors and consultants for the three months ended March 31, 2019 and 2018 of approximately $202,000 and $359,000, respectively, of which approximately $19,000 was recorded in discontinued operations in the first quarter of 2018. The compensation expense is allocated on a departmental basis, based on the classification of the option holder. No income tax benefits have been recognized in the statements of operations for stock-based compensation arrangements during any of the periods presented.

Stock compensation expense was allocated between departments in continuing operations as follows (in thousands).

	Three Months Ended March 31,
	2019		2018
Research and development	$	53	$	105
General and administrative		149		235
Total	$	202	$	340

Stock Options

The Company granted options to purchase 464,000 and 616,500 of the Company’s common stock during the three months ended March 31, 2019 and 2018, respectively. The fair value of each award granted was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions.

	Three Months Ended March 31,
	2019	2018
Expected life (years)	6.0-6.1	6.0
Risk-free interest rate	2.6%	2.7%
Volatility	71%	70%
Dividend rate	— %	— %

The Black-Scholes option-pricing model requires the use of highly subjective assumptions to estimate the fair value of stock-based awards. These assumptions include the following estimates:

•

Expected life: The expected life of stock options represents the average of the contractual term of the options and the weighted-average vesting period, as permitted under the simplified method. The Company does not believe it is able to rely on historical exercise and post-vesting termination activity to provide accurate data for estimating the expected term for use in estimating the fair value-based measurement of stock options. Therefore, it has opted to use the “simplified method” for estimating the expected term of options.

•

Risk-free interest rate: The risk-free interest rate is based on the yields of U.S. Treasury securities with maturities similar to the expected time to liquidity.

•

Volatility: The estimated volatility rate based on the volatilities of common stock of comparable companies in the Company’s industry.

•

Dividend rate: The Company has never declared or paid any cash dividends and does not presently plan to pay cash dividends in the foreseeable future. Consequently, the Company used an expected dividend yield of zero.

The following table summarizes stock option transactions for the three months ended March 31, 2019 as issued under the Plans:

	Shares Available			Number of Options			Weighted- Average Exercise Price per		Weighted Average Remaining Contractual Term
	for Grant			Outstanding			Share		(in years)
Balance at December 31, 2018		1,150,961			1,667,153		$	6.03		8.27
Additional shares authorized		223,742
Options granted		(464,000	)		464,000		$	1.67
Options exercised		—			—			—		—
Options canceled/forfeited		15,046			(15,046	)	$	8.83		—
Balance at March 31, 2019		925,749			2,116,107		$	5.05		8.43
Options vested at March 31, 2019					901,140		$	9.14		7.52
Options vested and expected to vest at March 31, 2019					2,116,107		$	5.05		8.43

The weighted-average grant date fair value of options granted was $1.08 and $1.03 per share for the three months ended March 31, 2019 and 2018, respectively. At March 31, 2019 total unrecognized employee stock-based compensation was $1.5 million, which is expected to be recognized over the weighted-average remaining vesting period of 2.9 years. As of March 31, 2019, the outstanding stock options had an intrinsic value of approximately $476,000.

Restricted Stock Units

There were 99,217 restricted stock units granted by the Company during the three months ended March 31, 2018 to employees and nonemployees. The shares were 100% vested on the grant date and were valued based on the Company’s common stock price on the grant date, with approximately $159,000 of the related stock-based compensation expense recognized at that time. There were no restricted stock units granted by the Company during the three months ended March 31, 2019.

2014 Employee Stock Purchase Plan

The Company’s board of directors and stockholders have adopted the 2014 Employee Stock Purchase Plan, or the ESPP. The ESPP has become effective, and the board of directors will implement commencement of offers thereunder in its discretion. A total of 27,967 shares of the Company’s common stock has been made available for sale under the ESPP. In addition, the ESPP provides for annual increases in the number of shares available for issuance under the plan on the first day of each year beginning in the year following the initial date that the board of directors authorizes commencement, equal to the least of:

•

1.0% of the outstanding shares of the Company’s common stock on the first day of such year;

•

55,936 shares; or

•

such amount as determined by the board of directors.

As of March 31, 2019, there were no purchases by employees under this plan.

Series D Warrants

The Company issued 256,064 Series D Warrants in October 2015, which are exercisable into 586,182 shares of the Company’s common stock, with an exercise price of $12.30 and a term of five years expiring on October 15, 2020. The Company’s Series D Warrants contain standard anti-dilution provisions for stock dividends, stock splits, subdivisions, combinations and similar types of recapitalization events. They also contain a cashless exercise feature that provides for their net share settlement at the option of the holder in the event that there is no effective registration statement covering the continuous offer and sale of the warrants and underlying shares. The Company is required to comply with certain requirements to cause or maintain the effectiveness of a registration statement for the offer and sale of these securities. The Series D Warrant agreement further provides for the payment of liquidated damages at an amount per month equal to 1% of the aggregate VWAP of the shares into which each Series D Warrant is convertible in the event that the Company is unable to maintain the effectiveness of a registration statement as described herein. The Company evaluated the registration payment arrangement stipulated in the terms of this securities agreement and determined that it is probable that the Company will maintain an effective registration statement and has therefore not allocated any portion of the proceeds to the registration payment arrangement. The Series D Warrant agreement specifically provides that under no circumstances will the Company be required to settle any Series D Warrant exercise for cash, whether by net settlement or otherwise.

Accounting Treatment

The Company accounts for the Series D Warrants in accordance with the guidance in ASC 815 Derivatives and Hedging. As indicated above, the Company is not required under any circumstance to settle any Series D Warrant exercise for cash. The Company has therefore classified the value of the Series D Warrants as permanent equity.

Other Common Stock Warrants

As of March 31, 2019, the Company had 102,070 common stock warrants outstanding from the 2010/2012 convertible notes, with an exercise price of $24.35 and a term of 10 years expiring in November 2024. The Company also had 16,500 common stock warrants issued to the underwriter in the Company’s IPO, with an exercise price of $35.70 and a term of 10 years, expiring in November 2024.

Note 9. Net loss per share

Basic net loss per share is computed by dividing net loss by the weighted-average number of common stock actually outstanding during the period. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common stock outstanding and dilutive potential common stock that would be issued upon the exercise of common stock warrants and options. For the three months ended March 31, 2019 and 2018, the effect of issuing the potential common stock is anti-dilutive due to the net losses in those periods and the number of shares used to compute basic and diluted earnings per share are the same in each of those periods.

The following potentially dilutive securities outstanding have been excluded from the computations of diluted weighted-average shares outstanding because such securities have an antidilutive impact due to losses reported (in common stock equivalent shares).

	As of March 31,
	2019		2018
Convertible preferred stock		—		714,200
Warrants issued to 2010/2012 convertible note holders to purchase common stock		102,070		102,070
Options to purchase common stock		2,116,107		1,551,310
Warrants issued in 2009 to purchase common stock		—		1,851
Warrants issued to underwriter to purchase common stock		16,500		16,500
Series A warrants to purchase common stock		485,121		485,121
Series C warrants to purchase common stock		118,083		118,083
Series D warrants to purchase common stock		586,162		586,182
2017 PIPE warrants		6,024,425		6,024,425
2018 PIPE warrants		513,617		—
Total		9,962,085		9,599,742

Note 10. Fair Value of Contingent Consideration

On March 7, 2017, the Company acquired Essentialis through the Merger of the Company’s wholly-owned subsidiary, Company E Merger Sub, Inc., a Delaware corporation, or the Merger Sub, whereby Merger Sub merged into Essentialis, with Essentialis surviving the Merger as a wholly owned subsidiary of the Company.

The transaction has been accounted for as an asset acquisition under the acquisition method of accounting. The amendments in ASU 2017-01 provide a screen to determine when a set of assets and activities is not a business. The screen requires that when substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single identifiable asset or a group of similar identifiable assets, the set of assets and activities is not a business.

Upon the achievement of certain commercial milestones associated with the sale of Essentialis’ product in accordance with the terms of the Merger Agreement, the Company is obligated to make cash earnout payments of up to a maximum of $30 million to Essentialis stockholders. The agreement to pay cash upon the achievement of the commercial milestones results in the recognition of a contingent consideration. The fair value of the contingent cash consideration is based on the Company’s analysis of the likelihood of the drug indication moving from phase II through approval in the Federal Drug Administration approval process and then reaching the cumulative revenue milestones.

Management engaged independent professional assistance and advice in order to assess the fair value of the contingent stock and cash consideration as of March 7, 2017 and December 31, 2017. During the process of determining the fair value of the contingent consideration at December 31, 2017, the Company became aware that certain of the subjective assumptions made at the time of the initial valuation should be modified based upon management’s increased understanding of the commercial capabilities of the DCCR drug. Accordingly, the Company determined that it was appropriate to adjust the provisional valuation amounts recorded for the contingent stock and cash consideration made at the inception in March 2017. As a result, the value of the contingent cash consideration to be paid upon completing successive sales milestones increased and the value of the contingent stock consideration payable upon timing milestones was reduced; the resulting combined change to the total contingent consideration was not material. The initial valuation of the contingent consideration determined the fair value of the contingent stock consideration to be $4.2 million and the fair value of the contingent cash consideration to be $1.1 million, for the combined value of $5.3 million. The revision of the initial valuation of the contingent consideration, made within the measurement period, determined the fair value of the contingent stock consideration to be $2.7 million and the fair value of the contingent cash consideration to be $2.6 million, for the combined value of $5.3 million.

Also subsequent to March 7, 2017 and prior to December 31, 2017, the Company completed its assessment of the tax effect on the net assets acquired by obtaining the independent study and report regarding the change in control in the previously outstanding stock of Essentialis. As a result of completing the study, the Company determined that, pursuant to Section 382 of the Internal Revenue Code, the utilization of Essentialis’s federal and state operating loss carryforwards were limited, which required the Company to record a net deferred tax liability in the amount of $1.7 million, deferred to future periods, as an element of the assets acquired. As a consequence of recording the net deferred tax liability, the Company’s valuation allowance was reduced by $1.7 million, which resulted in the provision for income tax benefit and an increase in the value of the intangible asset acquired.

The probability weighted milestone payments were discounted to determine the present value of future cash payments. The analysis utilized the weighted average cost of capital, or WACC, discount rate which was estimated to be 20%.

The fair value of the liability for the contingent consideration payable by the Company achieving the commercial sales milestones of $100 million and $200 million was initially established as $2.6 million at the time of the merger and $5.9 million at March 31, 2019, based on the Company’s assessment that it could reach the commercial sales milestones in 2024 and 2026, respectively.

Note 11. Compensation Plan for Board Members

In 2017, the Compensation Committee of the Board of Directors recommended, and the Board approved a revised compensation plan pursuant to which all board fees are paid in common stock of the Company. Payment to the Board of Directors in shares of the Company’s common stock is made after the close of the quarter in which the compensation is earned. During the three months ended March 31, 2019 and 2018, the Company issued 21,415 and 49,519 shares, respectively, of common stock to its Board members for fees earned.

Note 12. No Subsequent Events

The Company has evaluated its subsequent events from March 31, 2019 through the date these condensed consolidated financial statements were issued and has determined that there are no subsequent events requiring disclosure in these condensed consolidated financial statements.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operation

The interim consolidated financial statements included in this Quarterly Report on Form 10-Q and this Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the financial statements and notes thereto for the year ended December 31, 2018, and the related Management’s Discussion and Analysis of Financial Condition and Results of Operations, contained in the Company’s Form 10-K for the year ended December 31, 2018. In addition to historical information, this discussion and analysis contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements are subject to risks and uncertainties, including those set forth in Part II – Other Information, Item 1A. Risk Factors below and elsewhere in this report that could cause actual results to differ materially from historical results or anticipated results.

Overview

We were initially established as a diversified healthcare company that developed and commercialized innovative diagnostics, devices and therapeutics addressing unmet medical needs, which consisted of: precision metering of gas flow technology marketed as Serenz ^® Allergy Relief, or Serenz; CoSense ^® End-Tidal Carbon Monoxide (ETCO) Monitor, or CoSense, which measures ETCO and aids in the detection of excessive hemolysis, a condition in which red blood cells degrade rapidly and which can lead to adverse neurological outcomes; and, products that included temperature probes, scales, surgical tables, and patient surfaces.

On December 22, 2016, we entered into the Merger Agreement with Essentialis. Essentialis’s efforts prior to the Merger were focused primarily on developing and testing product candidates that target the ATP-sensitive potassium channel, a metabolically regulated membrane protein whose modulation has the potential to impact a wide range of rare metabolic, cardiovascular, and CNS diseases. Essentialis had tested DCCR as a treatment for PWS, a complex metabolic/neurobehavioral disorder. DCCR has orphan designation for the treatment of PWS in the U.S. as well as in the E.U. Consummation of the Merger was subject to various closing conditions, including our consummation of a financing of at least $8.0 million at, or substantially contemporaneous with, the closing of the Merger, which occurred on March 7, 2017 and the receipt of stockholder approval of the Merger at a special meeting of our stockholders, which was held on March 6, 2017. As a result, we now primarily focus on the development and commercialization of novel therapeutics for the treatment of rare diseases. Our current research and development efforts are primarily focused on advancing our lead candidate, DCCR tablets for the treatment of PWS, into late-stage clinical development.

Subsequent to March 7, 2017, we explored opportunities, and made a decision to divest, sell or otherwise dispose of the CoSense, NFI and Serenz businesses. Accordingly, and pursuant to ASC 205-20-45-10, the assets and liabilities related to the discontinued activities of CoSense, NFI and Serenz businesses are presented separately in the balance sheet as held for sale items, and the related operations reported herein for the CoSense, NFI and Serenz activities are reported as discontinued operations in the statements of operations until the time that the assets were disposed of. Our remaining ownership in Capnia is recorded as an investment and initially measured at fair value.

Our previously wholly-owned subsidiary NFI also marketed innovative pulmonary resuscitation solutions for the inpatient and ambulatory neonatal markets. We sold NFI in a stock transaction that was completed on July 18, 2017, pursuant to the NFI Purchase Agreement with Neoforce Holdings, a wholly-owned subsidiary of Flexicare Medical Limited, a privately-held United Kingdom company, for $720,000 and adjustments for inventory and the current cash balances held at NFI.

On December 4, 2017, we and our then wholly-owned subsidiary Capnia, entered into a joint venture with OAHL with the purpose of developing and commercializing CoSense with the intent to transfer ownership of Capnia to OAHL. During October 2018, Capnia issued 1,690,322 shares of its common stock to OAHL, representing 53% of its outstanding shares, after which we no longer hold a controlling interest in Capnia. Accordingly, we deconsolidated Capnia’s financial statements from ours and our remaining minority interest in Capnia is reported as a Minority interest investment in our consolidated balance sheet.

On July 27, 2018, the FDA has granted Fast Track designation to DCCR for the treatment of PWS. We are currently conducting a Phase III clinical trial of DCCR for the treatment of PWS.

As of March 31, 2019, we had an accumulated deficit of $134.1 million, primarily as a result of research and development and general and administrative expenses. While we may in the future generate revenue from a variety of sources, potentially including sales of our neonatology products, therapeutic products, other diagnostic products, license fees, milestone payments, and research and development payments in connection with potential future strategic partnerships, we have, to date, generated approximately $2,000 of revenue only from the 2013 license agreement pertaining to Serenz, approximately $2.7 million in revenue from our neonatology products and approximately $0.2 million in government grants; these activities are reported as discontinued operations in our accompanying consolidated financial statements. We may never be successful in commercializing our novel therapeutic and in

divesting, selling or otherwise disposing of our existing neonatology products or related therapeutic products. Accordingly, we expect to incur significant losses from operations for the foreseeable future, and there can be no assurance that we will ever generate significant revenue or profits.

Critical Accounting Policies and Significant Judgments and Estimates

Our management’s discussion and analysis of financial condition and results of operations are based upon our unaudited condensed consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. On an on-going basis, we evaluate our critical accounting policies and estimates. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions and conditions. Our significant accounting policies are more fully described in Note 3 of our most recent Form 10-K.

Results of Continuing Operations

Comparison of the three months ended March 31, 2019 and 2018, from continuing operations

	Three Months Ended March 31,						Increase (decrease)
	2019			2018			Amount			Percentage
	(in thousands)
Operating expenses:
Research and development	$	2,760		$	1,180		$	1,580			134	%
General and administrative		2,012			1,867			145			8	%
Change in fair value of contingent consideration		206			428			(222	)		52	%
Total operating expenses		4,978			3,475			1,503			43	%
Operating loss		(4,978	)		(3,475	)		(1,503	)		43	%
Other income (expense)
Cease-use income		—			3			(3	)		100	%
Change in fair value of warrants liabilities		(1,919	)		163			(2,082	)		1277	%
Loss from minority interest investment		(190	)		-			(190	)	n/a
Interest income		57			19			38			200	%
Total other income (expense)		(2,052	)		185			(2,237	)		1209	%
Loss from continuing operations		(7,030	)		(3,290	)		(3,740	)		114	%
Loss from discontinued operations		-			(514	)		514			100	%
Net loss	$	(7,030	)	$	(3,804	)	$	(3,226	)		85	%

Revenue

We have yet not commenced commercialization of DCCR, our current sole novel therapeutic product, and accordingly, through March 31, 2019, have generated no revenue from continuing operations.

Research and development expense

Research and development expense of $2.8 million for the three months ended March 31, 2019 increased by $1.6 million over the three months ended March 31, 2018, resulting primarily from the initiation of the Phase III clinical trial in May 2018. As of March 31, 2019, the Company has 15 clinical trial sites initiated and, as a result, increased clinical site costs, consulting costs, lab costs, and manufacturing costs for DCCR production. The Company's efforts until May 2018 were focused on preparation of the trials.

General and administrative expense

General and administrative expense of $2.0 million for the three months ended March 31, 2019 increased approximately $145,000 from the three months ended March 31, 2018. The increase is primarily a result of increased legal expense during the period, most of which related to intellectual property.

Change in fair value of contingent consideration

The approximate $206,000 for the three months ended March 31, 2019 represents the change in the fair value of the additional consideration that we expect to pay Essentialis stockholders based on our assessment of the expected likelihood of achieving commercial sales milestones of $100 million and $200 million in future years.

Other income (expense)

Other expense of $2.1 million in the three months ended March 31, 2019, decreased by $2.2 million from other income during the three months ended March 31, 2018. This decrease was primarily due to a $1.9 million increase in the fair value of the Company’s outstanding warrants during the three months ended March 31, 2019 compared to a decrease of approximately $163,000 during the three months ended March 31, 2018, as well an approximate $190,000 loss recorded on the Company’s minority interest investment in Capnia, its former subsidiary. These decreases were slightly offset by approximately $38,000 more of interest income recorded during the three months ended March 31, 2019 compared to March 31, 2018.

Results of Discontinued Operations

Discontinued operations during 2018 consist of our activities previously dedicated to the development and commercialization of innovative diagnostics, devices and therapeutics addressing unmet medical needs, which consisted of: precision metering of gas flow technology marketed as Serenz^® Allergy Relief, or Serenz; CoSense^® End-Tidal Carbon Monoxide (ETCO) Monitor, or CoSense, which measures ETCO and aids in the detection of excessive hemolysis, a condition in which red blood cells degrade rapidly; and, products that included temperature probes, scales, surgical tables and patient surfaces. In March 2017, we determined to divest, sell or otherwise dispose of the CoSense, Neo Force, Inc., and Serenz businesses in order to focus on the development and commercialization of novel therapeutics for the treatment of rare diseases. The discontinued operations for the development and commercialization of innovative diagnostic devices and therapeutics are summarized below.

Comparison of the three months ended March 31, 2019 and 2018, from discontinued operations

	Three Months Ended March 31,					Increase (decrease)
	2019		2018			Amount			Percentage
	(in thousands)
Product revenue	$	—	$	51		$	(51	)		100	%
Cost of product revenue		—		51			(51	)		100	%
Gross profit (loss)		—		—			-		n/a
Expenses:
Research and development		—		401			(401	)		100	%
Sales and marketing		—		11			(11	)		100	%
General and administrative		—		102			(102	)		100	%
Total expenses		—		514			(514	)		100	%
Net loss from discontinued operations	$	—	$	(514	)	$	514			100	%

All discontinued operations activity during the three months ended March 31, 2018 related to Capnia and its CoSense products. During October 2018, Capnia issued 53% of its outstanding shares of common stock to OAHL, leaving us with a noncontrolling interest. Accordingly, we deconsolidated Capnia’s financial statements from ours and our remaining minority interest in Capnia is reported as a minority interest investment in our condensed consolidated balance sheet. As Capnia is no longer a consolidated entity of ours, there is no corresponding discontinued operations activity for the three months ended March 31, 2019.

Liquidity and Capital Resources

We had a net loss of $7.0 million during the three months ended March 31, 2019 and an accumulated deficit of $134.1 million at March 31, 2019 from having incurred losses since our inception. We had $18.6 million of working capital at March 31, 2019 and used $3.7 million of cash in operating activities during the three months ended March 31, 2019. We have financed our operations principally through issuances of equity securities.

We have continued to focus on expense control, including reducing our workforce, eliminating outside consultants, reducing legal fees and implementing a plan to allow Board members to receive common stock, in lieu of cash payments.

We expect to continue incurring losses for the foreseeable future and may be required to raise additional capital to complete our clinical trials, pursue product development initiatives and penetrate markets for the sale of our products. We believe that we will continue to have access to capital resources through possible public or private equity offerings, debt financings, corporate collaborations or other means, but the access to such capital resources is uncertain and is not assured. If we are unable to secure additional capital, we may be required to curtail our clinical trials and development of new products and take additional measures to reduce costs in order to conserve our cash in amounts sufficient to sustain operations and meet our obligations. These measures could cause significant delays in our efforts to complete clinical trials and commercialize our products, which is critical to the realization of our business plan and our future operations. These matters raise substantial doubt about our ability to continue as a going concern within one year from the date of filing this quarterly report.

The accompanying condensed consolidated financial statements have been prepared under the assumption we will continue to operate as a going concern, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. The condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts of liabilities that may result from uncertainty related to our ability to continue as a going concern.

Cash flows

The following table sets forth the primary sources and uses of cash and cash equivalents for each of the periods presented below:

	Three Months Ended March 31,
	2019			2018
	(in thousands)
Net cash used in continuing operating activities	$	(3,687	)	$	(2,033	)
Net cash used in discontinued operating activities		-			(487	)
Net cash used in operating activities		(3,687	)		(2,520	)
Net cash used in continuing investing activities		(10	)		—
Net cash used in investing activities		(10	)		—
Net cash used in continuing financing activities		—			(112	)
Net cash provided by discontinued financing activities		—			400
Net cash provided by financing activities		—			288
Net decrease in cash, cash equivalents and restricted cash
Continuing operations		(3,697	)		(2,145	)
Discontinued operations		—			(87	)
Net decrease in cash, cash equivalents and restricted cash	$	(3,697	)	$	(2,232	)

Continuing Operations

Cash used in operating activities

During the three months ended March 31, 2019, operating activities used net cash of $3.7 million, which was primarily due to the loss from continuing operations of $7.0 million, adjusted for non-cash expenses of approximately $489,000 for depreciation and amortization, approximately $248,000 of expenses paid with common stock or equity awards, $2.1 million for the change in fair value of stock warrants and contingent consideration, and an approximate $190,000 operating loss on minority interest investment. Additionally, the usage of cash during the three months ended March 31, 2019 was reduced by approximately $291,000 due to increases in prepaid expenses, other current assets and other assets, amounts due from related parties, accounts payable, and accrued compensation and other current liabilities.

During the three months ended March 31, 2018, operating activities used net cash of $2.0 million, which was primarily due to the loss from continuing operations of $3.3 million, adjusted for non-cash expenses of approximately $492,000 for depreciation and amortization, approximately $423,000 of non-cash expenses paid with common stock or equity awards, and approximately $265,000 for the change in fair value of stock warrants and contingent consideration. There were also increases in prepaid expenses and other current assets and accounts payable and a decrease in accrued compensation and other current liabilities that offset the cash usage by a net of approximately $77,000.

Cash used in investing activities

Minimal cash was used for investing activities related to continuing operations in the three months ended March 31, 2019 for the costs of acquiring property and equipment. There were no investing activities during the three months ended March 31, 2018.

Cash provided by financing activities

There were no financing activities related to continued operations during the three months ended March 31, 2019. During the three months ended March 31, 2018 we paid approximately $112,000 of additional costs relating to the 2017 PIPE common stock and warrant issuance.

As of March 31, 2019, we had cash and cash equivalents of $19.4 million.

We believe that we do not have sufficient capital resources to sustain operations through at least the next twelve months from the date of this filing. We expect to continue incurring losses for the foreseeable future and may be required to raise additional capital to pursue our therapeutic product development initiatives. These conditions raise substantial doubt about our ability to continue as a going concern for a period of one year from the date of this report.

Discontinued Operations

Cash used in operating activities

There were no discontinued operations during the three months ended March 31, 2019, after the deconsolidation of Capnia in October 2018. During the three months ended March 31, 2018 we used net cash of $487,000 for discontinued operating activities, resulting primarily from the loss from discontinued operations of $514,000 partially offset by non-cash expenses associated with stock compensation.

Cash provided by investing activities

There were no investing activities related to discontinued operations during the three months ended March 31, 2019 or March 31, 2018.

Cash provided by financing activities

There were no financing activities related to discontinued operations during the three months ended March 31, 2019. Net cash provided by financing activities related to discontinued operations was approximately $400,000 during the three months ended March 31, 2018, representing the cash received during the period from our joint venture partner to fund the operations of Capnia. Capnia was deconsolidated in October 2018 upon a transfer of a controlling interest in the entity to our joint venture partner, OAHL.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements.

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

There have not been any material changes to our exposure to market risk during the three months ended March 31, 2019. For additional information regarding market risk, refer to the Qualitative and Quantitative Disclosures About Market Risk section of the Form 10-K.

Item 4.

Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in reports filed under the Securities Exchange Act of 1934, as amended, or the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in U.S. Securities and Exchange Commission, or SEC, rules and forms, and that such information is accumulated and communicated to our management to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of the end of the period covered by this Quarterly Report on Form 10-Q. Based upon that evaluation, our Chief

Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this Quarterly Report on Form 10-Q, our disclosure controls and procedures were effective.

(b) Changes in Internal Control over Financial Reporting

There have been no changes to our internal control over financial reporting that occurred during the first fiscal quarter ended March 31, 2019, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations on Effectiveness of Controls

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, even if determined effective and no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives to prevent or detect misstatements. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

PART II – OTHER INFORMATION

Item 1.

Legal Proceedings

We may, from time to time, be party to litigation and subject to claims that arise in the ordinary course of business. In addition, third parties may, from time to time, assert claims against us in the form of letters and other communications. We currently believe that these ordinary course matters will not have a material adverse effect on our business; however, the results of litigation and claims are inherently unpredictable. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

Item 1A.

Risk Factors

An investment in our securities has a high degree of risk. Before you invest you should carefully consider the risks and uncertainties. A description of factors that could materially affect our business, financial condition, or operating results is included under “Risk Factors” in Item 1A of Part I of our 2018 Annual Report on Form 10-K and is incorporated herein by reference. There have been no material changes to the risk factor disclosure since our 2018 Annual Report on Form 10-K. The risk factors described in our Form 10-K are not the only risks facing our company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial conditions and/or operating results. If any of these risks actually occur, our business, operating results and financial condition could be harmed, and the value of our stock could go down. This means you could lose all or a part of your investment.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3.

Defaults Upon Senior Securities

None.

Item 4.

Mine Safety Disclosures

Not applicable.

Item 5.

Other Information

The Company’s current focus is on the development of Diazoxide Choline Controlled-Release (DCCR) for patients with Prader-Willi syndrome (PWS). On July 30, 2018, the DCCR development program for PWS was granted Fast Track designation by the FDA.

DCCR is a once-a-day tablet formulation which is currently being evaluated in a Phase III program in approximately 105 patients being enrolled at multiple sites. The program consists of a three-month Phase III randomized, double-blind, placebo-controlled, parallel group study (also called C601 or DESTINY PWS) as well as a 9-month open-label safety extension study. All patients who complete the Phase III study are eligible to enroll into the open-label extension study (C602). The Company continues to enroll patients into its ongoing DESTINY PWS study, which commenced in May 2018 and is evaluating DCCR tablets for the treatment of Prader-Willi syndrome (PWS). To date, approximately 90% of the patients who have completed the DESTINY PWS study have elected to enroll in the C602 study.

At this time, 14 trial sites have been activated in the U.S., with additional sites anticipated to be added. The most recent sites activated are the National Institutes of Health in Bethesda, MD, Children’s Hospital Colorado in Aurora, CO, Nationwide Children’s Hospital in Columbus, OH, and University of California, Irvine, in Irvine, CA. Top-line data from the DESTINY PWS study is expected in late 2019.

On March 14, 2019, the Data Safety Monitoring Board (DSMB), the independent group of experts monitoring the safety of the DESTINY PWS study, recommended the continuation of the study without modification, which supports the Company’s understanding of DCCR’s safety.

Item 6.

Exhibits

See the Exhibit Index on the page immediately preceding the exhibits for a list of exhibits filed as part of this Quarterly Report on Form 10-Q, which Exhibit Index is incorporated herein by reference.

EXHIBIT INDEX

		Incorporated by Reference from
Exhibit Number	Description of Document	Registrant’s Form	Date Filed with the SEC	Exhibit Number	Filed Herewith

2.1	Stock Purchase Agreement, dated as of July 18, 2017, and between Soleno Therapeutics, Inc., a Delaware corporation, and NeoForce Holdings, Inc. a Delaware corporation	8-K	July 24, 2017	2.1

2.2	Joint Venture Agreement, dated as of December 4, 2017, by and among Soleno Therapeutics, Inc., Capnia, Inc., and OptAsia Healthcare Limited	8-K	December 8, 2017	2.1

2.3	PRC IP Purchase Agreement, dated as of December 4, 2017, by and between OptAsia Healthcare Limited and Capnia, Inc.	8-K	December 8, 2017	2.2

2.4	Transition Services Agreement, dated as of December 4, 2017, by and among Soleno Therapeutics, Inc., a Delaware corporation, Capnia, Inc. and OptAsia Healthcare, Ltd., a Hong Kong company	8-K	December 8, 2017	2.3

3.1	Amended and Restated Certificate of Incorporation of Soleno Therapeutics, Inc.	S-1/A	August 7, 2014	3.2

3.2	Amended and Restated Bylaws of Soleno Therapeutics, Inc.	S-1/A	July 1, 2014	3.4

3.3	Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock.	8-K	October 15, 2015	3.1

3.4	Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock	8-K	July 6, 2016	3.1

3.5	Certificate of Amendment	8-K	May 11, 2017	3.1

3.6	Certificate of Amendment to the Certificate of Incorporation	8-K	October 6, 2017	3.1

4.1	Form of the common stock certificate.	S-1/A	August 5, 2014	4.1

4.2	Amended And Restated Investors’ Rights Agreement, dated March 20, 2008, by and among Soleno Therapeutics, Inc. and certain holders of the Soleno Therapeutics, Inc.’s capital stock named therein.	S-1/A	July 1, 2014	4.2

4.3	Form of Series A Warrant Agreement.	S-1/A	August 5, 2014	4.3

4.4	Form of the Series A Warrant certificate.	S-1/A	August 5, 2014	4.4

4.5	Form of Underwriters’ Compensation Warrant.	S-1/A	August 5, 2014	4.5

4.6	Form of Convertible Promissory Note issued in February 2010 and March 2010 in connection with the 2010 convertible note financing.	S-1	June 10, 2014	4.6

4.7	Form of Warrant to Purchase Shares issued in February 2010 and March 2010 in connection with the 2010 convertible note financing.	S-1	June 10, 2014	4.7

		Incorporated by Reference from
Exhibit Number	Description of Document	Registrant’s Form	Date Filed with the SEC	Exhibit Number	Filed Herewith

4.8	Form of Convertible Promissory Note issued in November 2010 in connection with the 2010 convertible note financing.	S-1	June 10, 2014	4.8

4.9	Form of Warrant to Purchase Shares issued in November 2010 in connection with the 2010 convertible note financing.	S-1	June 10, 2014	4.9

4.10	Form of Convertible Promissory Note issued in January 2012 in connection with the 2012 convertible note financing.	S-1	June 10, 2014	4.10

4.11	Form of Warrant to Purchase Shares issued in January 2012 in connection with Soleno Therapeutics, Inc.’s 2012 convertible note financing.	S-1	June 10, 2014	4.11

4.12	Form of Convertible Promissory Note issued in July 2012 and August 2012 in connection with the 2012 convertible note financing.	S-1	June 10, 2014	4.12

4.13	Form of Warrant to Purchase Shares issued in July 2012 and August 2012 in connection with the 2012 convertible note financing.	S-1	June 10, 2014	4.13

4.14	Form of Convertible Promissory Note issued in April, August and October 2014 in connection with the 2014 convertible note financing.	S-1	June 10, 2014	4.14

4.15	Form of Warrant to Purchase Shares issued in April, August and October 2014 in connection with the 2014 convertible note financing.	S-1	June 10, 2014	4.15

4.16	Form of unit certificate.	S-1/A	August 5, 2014	4.16

4.17	Form of Series B Warrant Agreement.	S-1/A	November 4, 2014	4.17

4.18	Form of the Series B Warrant certificate.	S-1/A	November 4, 2014	4.18

4.19	Form of the Series C Warrant Agreement.	S-4	April 1, 2015	4.19

4.20	Form of the Series C Warrant certificate.	S-4	April 1, 2015	4.20

4.21	Form of Series D Common Stock Purchase Warrant.	8-K	October 15, 2015	4.1

4.22	Form of Placement Agent Warrant.	8-K	October 15, 2015	4.2

4.23	Form of Series D common stock Warrant Certificate.	8-K	October 15, 2015	4.3

4.24	Form of Series A Convertible Preferred Stock Certificate.	8-K	October 15, 2015	4.4

4.25	Form of Placement Agent Warrant.	8-K	July 6, 2016	4.1

4.26	Form of Series B Convertible Preferred Stock Certificate.	8-K	July 6, 2016	4.2

4.27	Form of Common Stock Purchase Warrant	8-K	December 13, 2017	4.1

4.28	Form of Common Stock Purchase Warrant	8-K	December 19, 2018	4.1

9.10	Form of Voting Agreement.	8-K	October 15, 2015	9.1

		Incorporated by Reference from
Exhibit Number	Description of Document	Registrant’s Form	Date Filed with the SEC	Exhibit Number	Filed Herewith

9.20	Form of Voting Agreement.	8-K	July 6, 2016	9.1

9.30	Form of Voting Agreement.	8-K	December 27, 2016	10.1

10.1	Form of Indemnification Agreement between the Registrant and each of its directors and executive officers.	S-1	June 10, 2014	10.1

10.2	1999 Incentive Stock Plan and forms of agreements thereunder.	S-1	June 10, 2014	10.2

10.3	2010 Equity Incentive Plan and forms of agreements thereunder.	S-1	June 10, 2014	10.3

10.4	2014 Equity Incentive Plan and forms of agreements thereunder.	S-1/A	July 1, 2014	10.4

10.5	2014 Employee Stock Purchase Plan and forms of agreements thereunder.	S-1/A	July 1, 2014	10.5

10.6	Offer Letter, dated June 22, 2007, by and between Soleno Therapeutics, Inc. and Ernest Mario, Ph.D.	S-1	June 10, 2014	10.6

10.7	Employment Agreement, dated April 6, 2010, by and between Soleno Therapeutics, Inc. and Anish Bhatnagar.	S-1	June 10, 2014	10.7

10.8	Offer Letter, dated May 29, 2013, between Soleno Therapeutics, Inc. and Anthony Wondka.	S-1	June 10, 2014	10.8

10.9	Offer Letter, dated April 17, 2014, by and between Soleno Therapeutics, Inc. and Antoun Nabhan.	S-1	June 10, 2014	10.9

10.10	Asset Purchase Agreement dated May 11, 2010, by and between Soleno Therapeutics, Inc. and BioMedical Drug Development Inc.	S-1	June 10, 2014	10.10

10.11	Convertible Note and Warrant Purchase Agreement, dated February 10, 2010, by and among Soleno Therapeutics, Inc. and the investors named therein.	S-1	June 10, 2014	10.11

10.12	Amendment No. 1 to Convertible Note and Warrant Purchase Agreement, Convertible Promissory Notes and Warrants to Purchase Shares, dated November 10, 2010, by and among Soleno Therapeutics, Inc. and the investors named therein.	S-1	June 10, 2014	10.12

10.13	Amendment No. 2 to Convertible Note and Warrant Purchase Agreement, Convertible Promissory Notes and Warrants to Purchase Shares, dated January 17, 2012, by and among Soleno Therapeutics, Inc. and the investors named therein.	S-1	June 10, 2014	10.13

10.14	Convertible Note and Warrant Purchase Agreement, dated January 16, 2012, by and among Soleno Therapeutics, Inc. and the investors named therein.	S-1	June 10, 2014	10.14

		Incorporated by Reference from
Exhibit Number	Description of Document	Registrant’s Form	Date Filed with the SEC	Exhibit Number	Filed Herewith

10.15	Omnibus Amendment to Convertible Note and Warrant Purchase Agreement, Convertible Promissory Notes and Warrants to Purchase Shares, dated July 31, 2012, by and among Soleno Therapeutics, Inc. and the investors named therein.	S-1	June 10, 2014	10.15

10.16	Omnibus Amendment to Convertible Promissory Notes and Warrants to Purchase Shares, dated April 28, 2014, by and among Soleno Therapeutics, Inc. and the investors named therein.	S-1	June 10, 2014	10.16

10.17	Convertible Note and Warrant Purchase Agreement, dated April 28, 2014, by and among Soleno Therapeutics, Inc. and the investors named therein.	S-1	June 10, 2014	10.17

10.18	Omnibus Amendment to Convertible Note and Warrant Purchase Agreement, Convertible Promissory Notes and Warrants to Purchase Shares, dated May 5, 2014, by and among Soleno Therapeutics, Inc. and the investors named therein.	S-1	June 10, 2014	10.18

10.19	Sublease, dated May 20, 2014, by and among Soleno Therapeutics, Inc. and Silicon Valley Finance Group.	S-1/A	July 1, 2014	10.19

10.20	Offer Letter, dated June 24, 2014, by and between Soleno Therapeutics, Inc. and David D. O’Toole.	S-1/A	July 22, 2014	10.20

10.21	Loan Agreement by and between Soleno Therapeutics, Inc. and the investors named therein, dated September 29, 2014.	S-1/A	September 29, 2014	10.21

10.22	Revised Second Tranche Closing Notice and Letter Amendment dated August 18, 2014 relating to the August 2014 Notes.	S-1/A	November 4, 2014	10.22

10.23	Second Tranche Subsequent Closing Notice and Letter Amendment dated October 22, 2014 relating to the October 2014 Notes.	S-1/A	November 4, 2014	10.23

10.24	Form of Warrant Exercise Agreement.	8-K	March 5, 2015	10.1

10.25	Advisory Agreement by and between Soleno Therapeutics, Inc. and Maxim Group LLC, dated March 4, 2015.	S-4	April 1, 2015	10.25

10.26	Agreement and First Amendment to Asset Purchase Agreement between the Company, BDDI and affiliate of BDDI, dated June 30, 2015.	8-K	July 7, 2015	10.1

10.27	Common Stock Purchase Agreement between the Company and an affiliate of BDDI, dated June 30, 2015.	8-K	July 7, 2015	10.2

		Incorporated by Reference from
Exhibit Number	Description of Document	Registrant’s Form	Date Filed with the SEC	Exhibit Number	Filed Herewith

10.28	Registration Rights Agreement between the Company and Aspire Capital Fund, LLC, dated July 24, 2015.	8-K	July 27, 2015	4.1

10.29	Common Stock Purchase Agreement between the Company and Aspire Capital Fund, LLC, dated July 24, 2015.	8-K	July 27, 2015	10.1

10.30	Engagement Letter dated September 17, 2015, between Soleno Therapeutics, Inc. and Maxim Group, LLC.	8-K	October 15, 2015	1.1

10.31	Securities Purchase Agreement dated October 12, 2015.	8-K	October 15, 2015	10.1

10.32	Form of Registration Rights Agreement.	8-K	October 15, 2015	10.2

10.33	Form of Lock-Up Agreement.	8-K	October 15, 2015	10.3

10.34	Amendment No. 1 to Securities Purchase Agreement dated October 29, 2015.	S-1/A	December 22, 2015	10.33

10.35	Transfer and Distribution Agreement: United States: by and between Soleno Therapeutics, Inc. and Bemes, Inc. signed January 26, 2016.	8-K	January 28, 2016	10.1

10.36	Engagement Letter dated June 26, 2016, between Soleno Therapeutics, Inc. and Maxim Group, LLC.	8-K	July 6, 2016	1.1

10.37	Securities Purchase Agreement dated June 29, 2016.	8-K	July 6, 2016	10.1

10.38	Form of Registration Rights Agreement dated June 29, 2016.	8-K	July 6, 2016	10.2

10.39	Amendment No. 1 to Securities Purchase Agreement dated September 20, 2016.	S-1/A	September 20, 2016	10.39

10.40	Agreement and Plan of Merger and Reorganization, dated as of December 22, 2016, by and among Soleno Therapeutics, Inc., a Delaware corporation, Essentialis, Inc., a Delaware corporation, Company E Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Soleno Therapeutics, and Neil Cowen as the stockholders’ representative.	8-K	December 27, 2016	2.1

10.41	Registration Rights Agreement between the Company and Aspire Capital Fund, LLC, dated January 27, 2017.	S-1	February 1, 2017	10.51

10.42	Common Stock Purchase Agreement between the Company and Aspire Capital Fund, LLC, dated January 27, 2017.	S-1	February 1, 2017	10.52

10.43	Stock Purchase Agreement made by and between the Company and NeoForce Holdings, Inc. a Delaware corporation dated July 18, 2017	8-K	July 24, 2017	2.1

		Incorporated by Reference from
Exhibit Number	Description of Document	Registrant’s Form	Date Filed with the SEC	Exhibit Number	Filed Herewith

10.44	Joint Venture Agreement dated as of December 4, 2017 by and among Soleno Therapeutics, Inc., Capnia, Inc., and OptAsia Healthcare Limited	8-K	December 8, 2017	2.1

10.45	Securities Purchase Agreement, dated as of December 11, 2017	8-K	December 13, 2017	10.1

10.46	Confidential Consulting Agreement, dated September 5, 2017 by and between FLG Partners, LLC and the Company	8-K	June 4, 2018	10.1

10.47	Securities Purchase Agreement, dated as of December 19, 2018	8-K	December 19, 2018	10.1

10.48	Employment Agreement with Kristen Yen.	S-1	March 29, 2019	10.48

31.1	Certification of Principal Executive Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities and Exchange Act of 1934, as amended				X

31.2	Certification of Principal Financial and Accounting Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities and Exchange Act of 1934, as amended				X

32.1	Certification of Principal Executive Officer Required Under Rule 13a-14(b) of the Securities and Exchange Act of 1934, as amended, and 18 U.S.C. §1350				X

32.2	Certification of Principal Financial and Accounting Officer Required Under Rule 13a-14(b) of the Securities and Exchange Act of 1934, as amended, and 18 U.S.C. §1350				X

101.INS	XBRL Instance Document.				X

101.SCH	XBRL Taxonomy Extension Schema Document.				X

101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document.				X

101.DEF	XBRL Taxonomy Extension Definition Linkbase Document.				X

101.LAB	XBRL Taxonomy Extension Label Linkbase Document.				X

101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document.				X

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: May 13, 2019	SOLENO THERAPEUTICS, INC.

	By:	/s/ Jonathan Wolter
		Jonathan Wolter Chief Financial Officer (authorized officer and principal financial and accounting officer)

EX-31.1 2 slno-ex311_9.htm EX-31.1 slno-ex311_9.htm

Exhibit 31.1

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER

PURSUANT TO

SECURITIES EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A)

I, Anish Bhatnagar, M.D., certify that:

1. I have reviewed this quarterly report on Form 10-Q of Soleno Therapeutics, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 13, 2019

/s/ Anish Bhatnagar

Anish Bhatnagar

President, Chief Executive Officer

(principal executive officer)

EX-31.2 3 slno-ex312_8.htm EX-31.2 slno-ex312_8.htm

Exhibit 31.2

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER

PURSUANT TO

SECURITIES EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A)

I, Jonathan Wolter, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Soleno Therapeutics, Inc.;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 13, 2019

/s/ Jonathan Wolter

Jonathan Wolter

Chief Financial Officer

(principal financial and accounting officer)

EX-32.1 4 slno-ex321_6.htm EX-32.1 slno-ex321_6.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Soleno Therapeutics, Inc. (the “Company”) on Form 10-Q for the fiscal quarter March 31, 2019, as filed with the Securities and Exchange Commission (the “Report”), Anish Bhatnagar, President, Chief Executive Officer of the Company does hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

•

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

•

The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 13, 2019

/s/ Anish Bhatnagar

Anish Bhatnagar

President, Chief Executive Officer

(principal executive officer)

EX-32.2 5 slno-ex322_7.htm EX-32.2 slno-ex322_7.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Soleno Therapeutics, Inc. (the “Company”) on Form 10-Q for the fiscal quarter ended March 31, 2019, as filed with the Securities and Exchange Commission (the “Report”), Jonathan Wolter, Chief Financial Officer of the Company does hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

•

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

•

The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 13, 2019

/s/ Jonathan Wolter

Jonathan Wolter

Chief Financial Officer

(principal financial and accounting officer)

EX-101.INS 6 slno-20190331.xml XBRL INSTANCE DOCUMENT xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure utr:sqft 0001484565 2019-01-01 2019-03-31 0001484565 2019-05-06 0001484565 2019-03-31 0001484565 2018-12-31 0001484565 slno:SeriesAWarrantsMember 2019-03-31 0001484565 slno:SeriesAWarrantsMember 2018-12-31 0001484565 slno:TwoThousandSeventeenPIPEWarrantLiabilityMember 2019-03-31 0001484565 slno:TwoThousandSeventeenPIPEWarrantLiabilityMember 2018-12-31 0001484565 slno:TwoThousandEighteenPIPEWarrantLiabilityMember 2019-03-31 0001484565 slno:TwoThousandEighteenPIPEWarrantLiabilityMember 2018-12-31 0001484565 us-gaap:SeriesBPreferredStockMember 2019-03-31 0001484565 us-gaap:SeriesBPreferredStockMember 2018-12-31 0001484565 2018-01-01 2018-03-31 0001484565 us-gaap:SeriesBPreferredStockMember 2017-12-31 0001484565 us-gaap:CommonStockMember 2017-12-31 0001484565 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001484565 us-gaap:RetainedEarningsMember 2017-12-31 0001484565 2017-12-31 0001484565 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0001484565 us-gaap:SeriesBPreferredStockMember 2018-01-01 2018-03-31 0001484565 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0001484565 us-gaap:AdditionalPaidInCapitalMember slno:TwoThousandSeventeenPIPEWarrantLiabilityMember 2018-01-01 2018-03-31 0001484565 slno:TwoThousandSeventeenPIPEWarrantLiabilityMember 2018-01-01 2018-03-31 0001484565 us-gaap:CommonStockMember slno:EssentialisIncMember 2018-01-01 2018-03-31 0001484565 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0001484565 us-gaap:SeriesBPreferredStockMember 2018-03-31 0001484565 us-gaap:CommonStockMember 2018-03-31 0001484565 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001484565 us-gaap:RetainedEarningsMember 2018-03-31 0001484565 2018-03-31 0001484565 us-gaap:CommonStockMember 2018-12-31 0001484565 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001484565 us-gaap:RetainedEarningsMember 2018-12-31 0001484565 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001484565 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001484565 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001484565 us-gaap:CommonStockMember 2019-03-31 0001484565 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001484565 us-gaap:RetainedEarningsMember 2019-03-31 0001484565 us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-03-31 0001484565 us-gaap:SegmentContinuingOperationsMember 2018-01-01 2018-03-31 0001484565 us-gaap:SegmentDiscontinuedOperationsMember 2018-01-01 2018-03-31 0001484565 slno:SeriesCWarrantsMember 2019-01-01 2019-03-31 0001484565 slno:TwoThousandSeventeenPIPEWarrantLiabilityMember 2019-01-01 2019-03-31 0001484565 slno:TwoThousandEighteenPIPEWarrantLiabilityMember 2019-01-01 2019-03-31 0001484565 slno:EssentialisIncMember 2016-12-22 2016-12-22 0001484565 slno:NeoForceHoldingsIncMember 2017-07-17 2017-07-18 0001484565 us-gaap:EquityUnitPurchaseAgreementsMember 2018-12-18 2018-12-19 0001484565 us-gaap:EquityUnitPurchaseAgreementsMember 2018-12-19 0001484565 us-gaap:CommonStockMember us-gaap:EquityUnitPurchaseAgreementsMember 2018-12-19 0001484565 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember slno:SeriesAWarrantsMember 2019-03-31 0001484565 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember slno:SeriesAWarrantsMember 2019-03-31 0001484565 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember slno:TwoThousandSeventeenPIPEWarrantLiabilityMember 2019-03-31 0001484565 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember slno:TwoThousandSeventeenPIPEWarrantLiabilityMember 2019-03-31 0001484565 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember slno:TwoThousandEighteenPIPEWarrantLiabilityMember 2019-03-31 0001484565 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember slno:TwoThousandEighteenPIPEWarrantLiabilityMember 2019-03-31 0001484565 slno:EssentialisIncMember us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0001484565 us-gaap:FairValueInputsLevel3Member slno:EssentialisIncMember us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0001484565 us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0001484565 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0001484565 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0001484565 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember slno:SeriesAWarrantsMember 2018-12-31 0001484565 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember slno:SeriesAWarrantsMember 2018-12-31 0001484565 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember slno:TwoThousandSeventeenPIPEWarrantLiabilityMember 2018-12-31 0001484565 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember slno:TwoThousandSeventeenPIPEWarrantLiabilityMember 2018-12-31 0001484565 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember slno:TwoThousandEighteenPIPEWarrantLiabilityMember 2018-12-31 0001484565 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember slno:TwoThousandEighteenPIPEWarrantLiabilityMember 2018-12-31 0001484565 slno:EssentialisIncMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001484565 us-gaap:FairValueInputsLevel3Member slno:EssentialisIncMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001484565 us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001484565 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001484565 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001484565 slno:SeriesAWarrantsMember slno:CommonStockWarrantLiabilityMember 2018-12-31 0001484565 slno:SeriesCWarrantsMember slno:CommonStockWarrantLiabilityMember 2018-12-31 0001484565 slno:TwoThousandSeventeenPIPEWarrantLiabilityMember slno:CommonStockWarrantLiabilityMember 2018-12-31 0001484565 slno:TwoThousandEighteenPIPEWarrantLiabilityMember slno:CommonStockWarrantLiabilityMember 2018-12-31 0001484565 slno:PurchasePriceContingentLiabilityMember 2018-12-31 0001484565 slno:SeriesAWarrantsMember slno:CommonStockWarrantLiabilityMember 2019-01-01 2019-03-31 0001484565 slno:TwoThousandSeventeenPIPEWarrantLiabilityMember slno:CommonStockWarrantLiabilityMember 2019-01-01 2019-03-31 0001484565 slno:TwoThousandEighteenPIPEWarrantLiabilityMember slno:CommonStockWarrantLiabilityMember 2019-01-01 2019-03-31 0001484565 slno:PurchasePriceContingentLiabilityMember 2019-01-01 2019-03-31 0001484565 slno:SeriesAWarrantsMember slno:CommonStockWarrantLiabilityMember 2019-03-31 0001484565 slno:SeriesCWarrantsMember slno:CommonStockWarrantLiabilityMember 2019-03-31 0001484565 slno:TwoThousandSeventeenPIPEWarrantLiabilityMember slno:CommonStockWarrantLiabilityMember 2019-03-31 0001484565 slno:TwoThousandEighteenPIPEWarrantLiabilityMember slno:CommonStockWarrantLiabilityMember 2019-03-31 0001484565 slno:PurchasePriceContingentLiabilityMember 2019-03-31 0001484565 slno:SeriesAWarrantsToPurchaseCommonStockMember us-gaap:IPOMember 2019-03-31 0001484565 slno:SeriesAWarrantsToPurchaseCommonStockMember us-gaap:IPOMember 2019-01-01 2019-03-31 0001484565 slno:SeriesAWarrantsMember 2019-01-01 2019-03-31 0001484565 slno:SeriesBWarrantsMember 2015-03-05 2015-03-05 0001484565 slno:SeriesBWarrantsMember 2015-03-05 0001484565 slno:SeriesCWarrantsMember 2015-03-05 0001484565 slno:SeriesCWarrantsMember 2015-03-05 2015-03-05 0001484565 slno:SeriesCWarrantsMember 2015-04-30 0001484565 slno:SeriesCWarrantsMember 2015-04-29 2015-04-30 0001484565 us-gaap:CommonStockMember slno:SeriesCWarrantsMember 2015-07-01 2015-07-31 0001484565 slno:SeriesCWarrantsMember 2015-07-01 2015-07-31 0001484565 slno:SeriesCWarrantsMember 2019-03-31 0001484565 slno:SeriesCWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2019-03-31 0001484565 slno:SeriesCWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2018-12-31 0001484565 slno:SeriesCWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2019-03-31 0001484565 slno:SeriesCWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2018-12-31 0001484565 slno:SeriesCWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2019-03-31 0001484565 slno:SeriesCWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2018-12-31 0001484565 slno:TwoThousandSeventeenPIPEWarrantLiabilityMember 2017-12-15 0001484565 slno:TwoThousandSeventeenPIPEWarrantLiabilityToPurchaseCommonStockMember srt:MinimumMember 2019-03-31 0001484565 us-gaap:MeasurementInputPriceVolatilityMember slno:TwoThousandSeventeenPIPEWarrantLiabilityMember 2019-03-31 0001484565 us-gaap:MeasurementInputPriceVolatilityMember slno:TwoThousandSeventeenPIPEWarrantLiabilityMember 2018-12-31 0001484565 us-gaap:MeasurementInputExpectedTermMember slno:TwoThousandSeventeenPIPEWarrantLiabilityMember 2019-03-31 0001484565 us-gaap:MeasurementInputExpectedTermMember slno:TwoThousandSeventeenPIPEWarrantLiabilityMember 2018-12-31 0001484565 us-gaap:MeasurementInputRiskFreeInterestRateMember slno:TwoThousandSeventeenPIPEWarrantLiabilityMember 2019-03-31 0001484565 us-gaap:MeasurementInputRiskFreeInterestRateMember slno:TwoThousandSeventeenPIPEWarrantLiabilityMember 2018-12-31 0001484565 slno:TwoThousandEighteenPIPEWarrantLiabilityMember 2018-12-19 0001484565 slno:TwoThousandEighteenPIPEWarrantLiabilityToPurchaseCommonStockMember srt:MinimumMember 2019-03-31 0001484565 us-gaap:MeasurementInputPriceVolatilityMember slno:TwoThousandEighteenPIPEWarrantLiabilityToPurchaseCommonStockMember 2019-03-31 0001484565 us-gaap:MeasurementInputPriceVolatilityMember slno:TwoThousandEighteenPIPEWarrantLiabilityToPurchaseCommonStockMember 2018-12-31 0001484565 us-gaap:MeasurementInputExpectedTermMember slno:TwoThousandEighteenPIPEWarrantLiabilityToPurchaseCommonStockMember 2019-03-31 0001484565 us-gaap:MeasurementInputExpectedTermMember slno:TwoThousandEighteenPIPEWarrantLiabilityToPurchaseCommonStockMember 2018-12-31 0001484565 us-gaap:MeasurementInputRiskFreeInterestRateMember slno:TwoThousandEighteenPIPEWarrantLiabilityToPurchaseCommonStockMember 2019-03-31 0001484565 us-gaap:MeasurementInputRiskFreeInterestRateMember slno:TwoThousandEighteenPIPEWarrantLiabilityToPurchaseCommonStockMember 2018-12-31 0001484565 us-gaap:MeasurementInputExpectedDividendRateMember 2019-03-31 0001484565 2015-07-01 0001484565 2015-07-01 2015-07-01 0001484565 2016-02-29 2016-03-01 0001484565 slno:OAHLMember slno:CapniaIncJointVentureMember us-gaap:CorporateJointVentureMember 2017-12-31 0001484565 slno:OAHLMember slno:CapniaIncJointVentureMember us-gaap:CorporateJointVentureMember 2018-09-30 0001484565 slno:OAHLMember slno:CapniaIncJointVentureMember us-gaap:CorporateJointVentureMember 2019-03-31 0001484565 slno:OAHLMember slno:CapniaIncJointVentureMember us-gaap:CorporateJointVentureMember 2018-10-16 2018-10-16 0001484565 2018-10-01 2018-12-31 0001484565 slno:CapniaIncJointVentureMember 2019-03-31 0001484565 slno:CapniaIncJointVentureMember 2019-01-01 2019-03-31 0001484565 slno:CosenseNFIandSerenzMember us-gaap:DiscontinuedOperationsHeldforsaleMember 2019-03-31 0001484565 slno:CosenseNFIandSerenzMember us-gaap:DiscontinuedOperationsHeldforsaleMember 2018-12-31 0001484565 slno:CosenseNFIandSerenzMember us-gaap:DiscontinuedOperationsHeldforsaleMember 2019-01-01 2019-03-31 0001484565 slno:CosenseNFIandSerenzMember us-gaap:DiscontinuedOperationsHeldforsaleMember 2018-01-01 2018-03-31 0001484565 us-gaap:DiscontinuedOperationsHeldforsaleMember 2018-01-01 2018-03-31 0001484565 us-gaap:DiscontinuedOperationsHeldforsaleMember 2019-01-01 2019-03-31 0001484565 srt:MinimumMember 2019-03-31 0001484565 us-gaap:EmployeeStockOptionMember srt:MinimumMember 2019-01-01 2019-03-31 0001484565 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-03-31 0001484565 slno:IncentiveStockOptionsMember srt:MaximumMember 2019-01-01 2019-03-31 0001484565 us-gaap:EmployeeStockOptionMember srt:MaximumMember 2019-01-01 2019-03-31 0001484565 us-gaap:EmployeeStockOptionMember 2019-03-31 0001484565 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-03-31 0001484565 us-gaap:ResearchAndDevelopmentExpenseMember us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-03-31 0001484565 us-gaap:ResearchAndDevelopmentExpenseMember us-gaap:SegmentContinuingOperationsMember 2018-01-01 2018-03-31 0001484565 us-gaap:GeneralAndAdministrativeExpenseMember us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-03-31 0001484565 us-gaap:GeneralAndAdministrativeExpenseMember us-gaap:SegmentContinuingOperationsMember 2018-01-01 2018-03-31 0001484565 srt:MinimumMember 2019-01-01 2019-03-31 0001484565 srt:MaximumMember 2019-01-01 2019-03-31 0001484565 us-gaap:EmployeeStockOptionMember 2018-12-31 0001484565 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-12-31 0001484565 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-03-31 0001484565 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-03-31 0001484565 us-gaap:EmployeeStockMember 2019-03-31 0001484565 us-gaap:EmployeeStockMember 2019-01-01 2019-03-31 0001484565 slno:SeriesDWarrantsMember 2015-10-31 0001484565 slno:SeriesDWarrantsMember 2015-10-01 2015-10-31 0001484565 slno:WarrantsToPurchaseCommonStockMember slno:TwoThousandAndTenAndTwoThousandAndTwelveConvertiblePromissoryNotesMember 2019-03-31 0001484565 slno:WarrantsToPurchaseCommonStockMember slno:TwoThousandAndTenAndTwoThousandAndTwelveConvertiblePromissoryNotesMember 2019-01-01 2019-03-31 0001484565 slno:UnderwriterMember 2019-03-31 0001484565 slno:UnderwriterMember 2019-01-01 2019-03-31 0001484565 us-gaap:ConvertiblePreferredStockMember 2018-01-01 2018-03-31 0001484565 us-gaap:ConvertibleDebtSecuritiesMember 2019-01-01 2019-03-31 0001484565 us-gaap:ConvertibleDebtSecuritiesMember 2018-01-01 2018-03-31 0001484565 us-gaap:StockOptionMember 2019-01-01 2019-03-31 0001484565 us-gaap:StockOptionMember 2018-01-01 2018-03-31 0001484565 us-gaap:WarrantMember 2018-01-01 2018-03-31 0001484565 slno:UnderwriterMember 2018-01-01 2018-03-31 0001484565 slno:SeriesAWarrantsToPurchaseCommonStockMember 2019-01-01 2019-03-31 0001484565 slno:SeriesAWarrantsToPurchaseCommonStockMember 2018-01-01 2018-03-31 0001484565 slno:SeriesCWarrantToPurchaseCommonStockMember 2019-01-01 2019-03-31 0001484565 slno:SeriesCWarrantToPurchaseCommonStockMember 2018-01-01 2018-03-31 0001484565 slno:SeriesDWarrantToPurchaseCommonStockMember 2019-01-01 2019-03-31 0001484565 slno:SeriesDWarrantToPurchaseCommonStockMember 2018-01-01 2018-03-31 0001484565 slno:TwoThousandSeventeenPIPEWarrantLiabilityMember 2018-01-01 2018-03-31 0001484565 slno:EssentialisIncMember slno:EarnoutPaymentsMember 2017-03-07 0001484565 2017-03-06 2017-03-07 0001484565 us-gaap:ChangeDuringPeriodFairValueDisclosureMember 2017-12-30 2017-12-31 0001484565 slno:EssentialisIncMember 2017-12-31 0001484565 slno:EssentialisIncMember 2017-03-08 2017-12-31 0001484565 slno:EssentialisIncMember us-gaap:MeasurementInputDiscountRateMember 2017-03-07 0001484565 2017-03-07 0001484565 us-gaap:DirectorMember 2019-01-01 2019-03-31 0001484565 us-gaap:DirectorMember 2018-01-01 2018-03-31 10-Q false 2019-03-31 2019 Q1 SLNO SOLENO THERAPEUTICS INC 0001484565 --12-31 Non-accelerated Filer true true false 31776584

19402000

23099000

603000

529000

72000

64000

788000 978000

20865000

24670000

19000

12000

17983000

18469000

38867000

43151000

1258000

934000

992000

943000

2250000

1877000

73000

49000

6274000

4563000

784000

600000

5855000 5649000

15236000

12738000

32000

157661000

157413000

-134062000

-127032000

23631000

30413000

38867000

43151000

0.001

10000000

0.001

13780

0.001

100000000

31776584

31755169

31776584

31755169

2760000

1180000

2012000

1867000

206000 428000

4978000

3475000

-4978000

-3475000

3000

1919000

-163000

-190000

57000

19000

-2052000

185000

-7030000

-3290000

-514000

-7030000

-3804000

-0.22

-0.17

-0.02

-0.22

-0.19

31756120

19530311

4571

19238972

19000

140495000

-113697000

26817000

200000

-1000

200000

1000

99217

159000

49519

82000

203000

180667

-3804000

3571

19768375

20000

140733000

-117501000

23252000

31755169

32000

157413000

-127032000

202000

21415

46000

-7030000

31776584

32000

157661000

-134062000

-7030000

-3804000

489000

492000

202000

341000

46000

82000

-190000

74000

80000

8000

324000

409000

49000

-252000

-3687000

-2033000

-487000

-3687000

-2520000

10000

-10000

112000

-112000

400000

288000

-3697000

-2145000

-87000

-3697000

-2232000

-2000

23099000

17135000

19402000

14901000

91000

Note 1. Overview <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Soleno Therapeutics, Inc. (the “Company” or “Soleno”) was incorporated in the State of Delaware on August 25, 1999, and is located in Redwood City, California. On May 8, 2017, Soleno received stockholder approval to amend its Amended and Restated Certificate of Incorporation to change its name from “Capnia, Inc.” to “Soleno Therapeutics, Inc.” The Company was initially established as a diversified healthcare company that developed and commercialized innovative diagnostics, devices and therapeutics addressing unmet medical needs, which consisted of: precision metering of gas flow technology marketed as Serenz ® Allergy Relief, or Serenz; CoSense ® End-Tidal Carbon Monoxide (ETCO) Monitor, or CoSense, which measures ETCO and aids in the detection of excessive hemolysis, a condition in which red blood cells degrade rapidly and which can lead to adverse neurological outcomes; and, products that included temperature probes, scales, surgical tables, and patient surfaces. <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s previously wholly-owned subsidiary, NeoForce, Inc., or NFI, through which the Company acquired substantially all of the assets of an unrelated privately-held company, NeoForce Group, Inc., or NeoForce, also marketed innovative pulmonary resuscitation solutions for the inpatient and ambulatory neonatal markets. <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company acquired Essentialis, Inc., or Essentialis, through a merger, or the Merger, on March 7, 2017, pursuant to Agreement and Plan of Merger dated December 22, 2016. Essentialis’s efforts prior to the Merger were focused primarily on developing and testing product candidates that target the ATP-sensitive potassium channel, a metabolically regulated membrane protein whose modulation has the potential to impact a wide range of rare metabolic, cardiovascular, and CNS diseases. Essentialis has tested Diazoxide Choline Controlled Release Tablet, or DCCR, as a treatment for Prader-Willi Syndrome, or PWS, a complex metabolic/neurobehavioral disorder. DCCR has orphan designation for the treatment of PWS in the United States, or U.S., as well as in the European Union, or E.U. Consummation of the Merger was subject to various closing conditions, including the Company’s consummation of a financing of at least $8.0 million at, or substantially contemporaneous with, the closing of the Merger, which occurred on March 7, 2017 and the receipt of stockholder approval of the Merger at a special meeting of its stockholders, which was held on March 6, 2017. Subsequent to the acquisition of Essentialis, the Company determined to divest, sell or otherwise dispose of the CoSense, NFI and Serenz businesses. Accordingly, and pursuant to ASC 205-20-45-10, any assets and liabilities related to the discontinued activities of CoSense, NFI and Serenz have been presented separately in the balance sheet as held for sale items, and the related operations reported herein for the CoSense, NFI and Serenz activities are reported as discontinued operations in the statements of operations. The Company determined to divest, sell or otherwise dispose of the CoSense, NFI and Serenz businesses in order to focus on the development and commercialization of novel therapeutics for the treatment of rare diseases. The Company’s current research and development efforts are primarily focused on advancing its lead candidate, DCCR tablets for the treatment of PWS, into late-stage clinical development. <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company sold its entire interest in NFI in a stock transaction that was completed on July 18, 2017, pursuant to a Stock Purchase Agreement dated July 18, 2017, or the NFI Purchase Agreement, entered into with Neoforce Holdings, Inc., a wholly-owned subsidiary of Flexicare Medical Limited, a privately-held United Kingdom company, for $720,000 and adjustments for inventory and the current cash balances held at NFI. On December 4, 2017, Soleno, and Capnia, Inc., a Delaware corporation, or Capnia, entered into a joint venture with OptAsia Healthcare Limited, or OAHL. The purpose of the joint venture is to develop and commercialize medical monitors, including CoSense, that measure end-tidal carbon monoxide in breath to assist in the detection of excessive hemolysis in neonates, a condition in which red blood cells degrade rapidly and which can lead to adverse neurological outcomes. The Company has previously charged to expense all previously-held assets related to its Serenz operations, and there are no remaining Serenz assets, liabilities or operations related to the Company’s previous Serenz-related business.

Note 4. Fair Value of Financial Instruments The carrying value of the Company’s cash, restricted cash, cash equivalents and accounts payable, approximate fair value due to the short-term nature of these items. Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows: <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap">  </td> <td valign="top" style="width:3.4%;white-space:nowrap"> •</td> <td valign="top"> Level I — Unadjusted quoted prices in active markets for identical assets or liabilities; </td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap">  </td> <td valign="top" style="width:3.4%;white-space:nowrap"> •</td> <td valign="top"> Level II — Inputs other than quoted prices included within Level I that are observable, unadjusted quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and </td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap">  </td> <td valign="top" style="width:3.4%;white-space:nowrap"> •</td> <td valign="top"> Level III — Unobservable inputs that are supported by little or no market activity for the related assets or liabilities. </td></tr></table></div> The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands).   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="14" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value Measurements at March 31, 2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liabilities</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Series A warrant liability</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Series C warrant liability</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2017 PIPE warrant liability</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,274</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,274</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2018 PIPE warrant liability</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">784</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">784</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Essentialis purchase price contingency liability</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,855</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,855</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total common stock warrant and contingent <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   consideration liability</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,986</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,913</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table>   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="14" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value Measurements at December 31, 2018</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liabilities</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Series A warrant liability</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Series C warrant liability</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2017 PIPE warrant liability</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,563</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,563</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2018 PIPE warrant liability</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">600</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">600</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Essentialis purchase price contingency liability</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,649</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,649</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total common stock warrant and contingent <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   consideration liability</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,861</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,812</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div></div>   The Series A Warrant is a registered security that trades on the open market and the fair value of the Series A Warrant liability is based on the publicly quoted trading price of the warrants which is listed on and obtained from NASDAQ. Accordingly, the fair value of Series A Warrants is a Level 1 measurement. The fair value measurement of the Series C Warrants is based on significant inputs that are unobservable and thus represent Level 3 measurements. The Company’s estimated fair value of the Series C Warrant liability is calculated using the Black-Scholes valuation model, which is equivalent to fair value computed using the Binomial Lattice Option Model. Key assumptions include the volatility of the Company’s stock, the expected warrant term, expected dividend yield and risk-free interest rates. The Company’s estimated fair value of the 2017 PIPE Warrants and the 2018 PIPE Warrants was calculated using a Monte Carlo simulation of a geometric Brownian motion model. The Monte Carlo simulation pricing model requires the input of highly subjective assumptions including the expected stock price volatility, the expected term, the expected dividend yield and the risk-free interest rate. The fair value of the Essentialis purchase price contingent liability is estimated using scenario-based methods based upon the Company’s analysis of the likelihood of obtaining specified approvals from the Federal Drug Administration as well as reaching cumulative revenue milestones (see Note 10). The Level 3 estimates are based, in part, on subjective assumptions. During the periods presented, the Company has not changed the manner in which it values liabilities that are measured at fair value using Level 3 inputs. The Company recognizes transfers between levels of the fair value hierarchy as of the end of the reporting period. There were no transfers within the hierarchy during the periods presented. The following table sets forth a summary of the changes in the fair value of the Company’s Level 1 and Level 3 warrants, which are treated as liabilities (dollars in thousands).   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:31.06%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series A Warrant</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series C Warrant</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017 PIPE Warrants</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018 PIPE Warrants</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:5.9%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Purchase Price</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:31.06%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Warrants</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liability</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Warrants</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liability</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Warrants</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liability</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Warrants</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liability</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contingent <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liability</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.06%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2018</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">485,121</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,083</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,024,425</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,563</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">513,617</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">600</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,649</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.06%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in value of Series A Warrants</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.06%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in value of 2017 PIPE Warrants</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,711</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.06%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in value of 2018 PIPE Warrants</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">184</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:31.06%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in value of contingent liability</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">206</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:31.06%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at March 31, 2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">485,121</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,083</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,024,425</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,274</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">513,617</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">784</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,855</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>

Note 5. Warrant Liabilities The Company has issued multiple warrant series, of which the Series A Warrants, Series C Warrants, the 2017 PIPE Warrants and the 2018 PIPE Warrants (the “Warrants”) are considered liabilities pursuant to the guidance established by ASC 815 Derivatives and Hedging. Accounting Treatment The Company accounts for the Warrants in accordance with the guidance in ASC 815. As indicated below, the Company may be obligated to settle Warrants in cash in the case of a Fundamental Transaction (as defined in the Warrants). The Company classified the Warrants, with a term greater than one year, as long-term liabilities at their fair value and will re-measure the warrants at each balance sheet date until they are exercised or expire. Any change in the fair value is recognized as other income (expense) in the Company’s condensed consolidated statements of operations. Series A Warrants The Company has issued 489,921 Series A Warrants to purchase shares of its common stock at an exercise price of $32.50 per share in connection with the unit offering offered in the Company’s initial public offering, or the IPO, in November 2014. The Series A Warrants are exercisable at any time prior to the expiration of the five-year term on November 12, 2019. Upon the completion of the IPO, the Series A Warrants started trading on the NASDAQ under the symbol SLNOW. As the Series A Warrants are publicly traded, the Company uses the closing price on the measurement date to determine the fair value of the Series A Warrants. The Series A Warrants contract further provides for the payment of liquidated damages at an amount per month equal to 1% of the aggregate volume weighted average price, or VWAP, of the shares into which each Warrant is convertible in the event that the Company is unable to maintain the effectiveness of a registration statement as described herein. The Company evaluated the registration payment arrangement stipulated in the terms of these securities and determined that it is probable that the Company will maintain an effective registration statement and has therefore not allocated any portion of the proceeds related to the warrant financings to the registration payment arrangement. The Warrants also contain a fundamental transactions provision that permits their settlement in cash at fair value at the option of the holder upon the occurrence of a change in control. Such change in control events include tender offers or hostile takeovers, which are not within the sole control of the Company as the issuer of these warrants. Accordingly, the Warrants are considered to have a cash settlement feature that precludes their classification as equity instruments. Settlement at fair value upon the occurrence of a fundamental transaction would be computed using the Black Scholes Option Pricing Model, which approximates the binomial lattice model. Since their issuance, a total of 4,800 Series A Warrants have been exercised. As of March 31, 2019, the fair value of the 485,121 outstanding Series A Warrants was approximately $73,000 and the increase of approximately $24,000 in fair value during the three months ended March 31, 2019 was recorded as other income (expense) in the condensed consolidated statements of operations. Series C Warrants On March 5, 2015, the Company entered into separate agreements with certain Series B Warrant holders, who agreed to exercise their Series B Warrants to purchase an aggregate of 117,902 shares of the Company’s common stock at an exercise price of $32.50 per share, resulting in the de-recognition of $6.7 million of the previously issued Series B Warrant liability and gross proceeds to the Company of $3.8 million based on the exercise price of the Series B Warrants. In connection with this exercise of the Series B Warrants, the Company issued to each investor who exercised Series B Warrants, new Series C Warrants for the number of shares of the Company’s common stock underlying the Series B Warrants that were exercised. Each Series C Warrant is exercisable at $31.25 per share and will expire on March 5, 2020. The Series C Warrants contract further provides for the payment of liquidated damages at an amount per month equal to 1% of the aggregate volume weighted average price, or VWAP, of the shares into which each Warrant is convertible in the event that the Company is unable to maintain the effectiveness of a registration statement as described herein. The Company evaluated the registration payment arrangement stipulated in the terms of these securities and determined that it is probable that the Company will maintain an effective registration statement and has therefore not allocated any portion of the proceeds related to the warrant financings to the registration payment arrangement. The Warrants also contain a fundamental transactions provision that permits their settlement in cash at fair value at the option of the holder upon the occurrence of a change in control. Such change in control events include tender offers or hostile takeovers, which are not within the sole control of the Company as the issuer of these warrants. Accordingly, the Warrants are considered to have a cash settlement feature that precludes their classification as equity instruments. Settlement at fair value upon the occurrence of a fundamental transaction would be computed using the Black Scholes Option Pricing Model, which approximates the binomial lattice model. In April 2015, the Company issued a tender offer to the remaining holders of Series B Warrants to induce the holders to cash exercise the outstanding Series B Warrants in exchange for new Series C Warrants with an exercise price of $31.25 per share that expire on March 5, 2020. The tender offer was extended to Series B Warrant holders under a registration statement filed with the SEC on Form S-4, which was declared effective on June 25, 2015 and expired on July 24, 2015. During July 2015, certain Series B Warrant holders tendered their Series B Warrants under the tender offer, which resulted in the issuance of 181 shares of the Company’s common stock, the issuance of 181 Series C Warrants and proceeds to the Company of approximately $6,000. The Series C Warrants are exercisable into 118,083 shares of the Company’s common stock. As of March 31, 2019, the fair value of the Series C Warrants was determined to be zero, consistent with the balance as of December 31, 2018. The Company has calculated the fair value of the Series C Warrants using a Black-Scholes pricing model. The Black-Scholes pricing model requires the input of highly subjective assumptions including the expected stock price volatility. The Company used the following inputs.   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March 31, <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Volatility</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contractual term (years)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.92</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.17</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free rate</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.41</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.60</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> </tr> </table>  </div> Warrants Issued as Part of the Units in the 2017 PIPE Offering The 2017 PIPE Warrants were issued on December 15, 2017 in the 2017 PIPE Offering, pursuant to a Warrant Agreement with each of the investors in the 2017 PIPE Offering, and entitle the holder to purchase one share of the Company’s common stock at an exercise price equal to $2.00 per share, subject to adjustment as discussed below, at any time commencing upon issuance of the 2017 PIPE Warrants and terminating at the earlier of December 15, 2020 or 30 days following positive Phase III results for the DCCR tablet in PWS. The exercise price and number of shares of common stock issuable upon exercise of the 2017 PIPE Warrants may be adjusted in certain circumstances, including the event of a stock split, stock dividend, extraordinary dividend, or recapitalization, reorganization, merger or consolidation. However, the exercise price of the 2017 PIPE Warrants will not be reduced below $1.72. In the event of a change of control of the Company, the holders of unexercised warrants may present their unexercised warrants to the Company, or its successor, to be purchased by the Company, or its successor, in an amount equal to the per share value determined by the Black Scholes methodology. As of March 31, 2019, the fair value of the 2017 PIPE Warrants was estimated at $6.3 million. The increase in the fair value of the liability for the 2017 PIPE Warrants of approximately $1.7 million during the three months ended March 31, 2019 was recorded as other income (expense) in the condensed consolidated statements of operations.  The Company has calculated the fair value of the 2017 PIPE Warrants using a Monte Carlo simulation of a geometric Brownian motion model. The Monte Carlo simulation pricing model requires the input of highly subjective assumptions including the expected stock price volatility. The following summarizes certain key assumptions used in estimating the fair values.   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March 31, <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Volatility</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contractual term (years)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.7</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.0</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free rate</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.40</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.51</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> </tr> </table>  </div> Warrants Issued as Part of the Units in the 2018 PIPE Offering The 2018 PIPE Warrants were issued on December 19, 2018 in the 2018 PIPE Offering, pursuant to a Warrant Agreement with each of the investors in the 2018 PIPE Offering, and entitle the holders of each of the 10,272,375 units to purchase 0.05 shares of the Company’s common stock at an exercise price equal to $2.00 per share, subject to adjustment as discussed below, at any time commencing upon issuance of the 2018 PIPE Warrants and terminating on December 21, 2023.   The exercise price and number of shares of common stock issuable upon exercise of the 2018 PIPE Warrants may be adjusted in certain circumstances, including the event of a stock split, stock dividend, extraordinary dividend, or recapitalization, reorganization, merger or consolidation. However, the exercise price of the 2018 PIPE Warrants will not be reduced below $2.00. In the event of a change of control of the Company, the holders of unexercised warrants may present their unexercised warrants to the Company, or its successor, to be purchased by the Company, or its successor, in an amount equal to the per share value determined by the Black Scholes methodology. As of March 31, 2019, the fair value of the 2018 PIPE Warrants was estimated at approximately $784,000. The approximate $184,000 increase in the fair value of the liability for the 2018 PIPE Warrants during the three months ended March 31, 2019 was recorded as other income (expense) in the condensed consolidated statements of operations.  The Company has calculated the fair value of the 2018 PIPE Warrants using a Monte Carlo simulation of a geometric Brownian motion model. The Monte Carlo simulation pricing model requires the input of highly subjective assumptions including the expected stock price volatility. The following summarizes certain key assumptions used in estimating the fair values.   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March 31, <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Volatility</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contractual term (years)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.7</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.0</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free rate</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.23</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.51</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> </tr> </table>  </div> The Monte Carlo simulation of a geometric Brownian motion model requires the use of highly subjective assumptions to estimate the fair value of stock-based awards. These assumptions include the following estimates. <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap">  </td> <td valign="top" style="width:3.4%;white-space:nowrap"> •</td> <td valign="top"> Volatility: The Company calculates the estimated volatility rate based on the volatilities of common stock of comparable companies in its industry.</td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap">  </td> <td valign="top" style="width:3.4%;white-space:nowrap"> •</td> <td valign="top"> Contractual term: The expected life of the warrants, which is based on the contractual term of the warrants.</td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap">  </td> <td valign="top" style="width:3.4%;white-space:nowrap"> •</td> <td valign="top"> Expected dividend yield: The Company has never declared or paid any cash dividends and does not currently plan to pay cash dividends in the foreseeable future. Consequently, the Company used an expected dividend yield of zero.</td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.54%;white-space:nowrap">  </td> <td valign="top" style="width:3.4%;white-space:nowrap"> •</td> <td valign="top"> Risk-free rate: The risk-free interest rate is based on the U.S. Treasury rate for similar periods as those of expected volatility.</td></tr></table></div>

Recent Accounting Standards Recently Adopted Accounting Standards In June 2018, the FASB issued ASU 2018-07, “Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting”, to simplify the accounting for share-based payments to nonemployees by aligning it with the accounting for share-based payments to employees, with certain exceptions. Under the guidance, the measurement of equity-classified nonemployee awards is fixed at the grant date, which may lower the cost and reduce volatility in the income statement. This ASU was early adopted by the Company at the beginning of 2019.  Its adoption did not have a material impact on the Company’s condensed consolidated financial statements. In August 2018, SEC adopted the final rule under SEC Release No. 33-10532, “Disclosure Update and Simplification”, amending certain disclosure requirements that were redundant, duplicative, overlapping, outdated or superseded. In addition, the amendments expanded the disclosure requirements on the analysis of stockholders’ equity for interim financial statements. Under the amendments, an analysis of changes in each caption of stockholders’ equity presented in the balance sheet must now be provided in a note or separate statement. The Company has applied this new guidance to its condensed financial statements for the first quarter of 2019. Recently Issued Accounting Standards In February 2016, the FASB issued ASU 2016-02: “Leases (Topic 842)”. ASU 2016-02 provides new comprehensive lease accounting guidance that supersedes existing lease guidance. Upon adoption of ASU 2016-02, the Company may elect to apply the transition approach either as of the beginning of the earliest period presented in the financial statements – in which case it would restate its comparative periods, or as of the beginning of the period of adoption – in which case it would not restate its comparative periods. ASU 2016-02 requires the Company to capitalize most current operating lease obligations as right-of-use assets with a corresponding liability based on the present value of future operating lease obligations. Criteria for distinguishing leases between finance and operating are substantially similar to criteria for distinguishing between capital leases and operating leases in existing lease guidance. Lease agreements that are 12 months or less are permitted to be excluded from the balance sheet. Topic 842 includes a number of optional practical expedients that the Company may elect to apply. Expanded disclosures with additional qualitative and quantitative information will also be required. The adoption will include updates as provided under ASU 2018-01, Leases (Topic 842): Land Easement Practical Expedient for Transition to Topic 842, ASU 2018-10, Codification Improvements to Topic 842, Leases, ASU 2018-20, Leases (Topic 842): Narrow-Scope Improvements for Lessors and ASU 2019-01, Leases (Topic 842): Codification Improvements. Topic 842 is effective for public entities with fiscal years beginning after December 15, 2018 and for all other entities for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. As the Company is an emerging growth company and elected to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act, Topic 842 will be effective for the Company beginning in fiscal 2020, although early adoption is permitted. The Company is currently evaluating the potential impact of adoption of this standard on its condensed consolidated financial statements and the additional transition method under ASU 2018-11, which allows the Company to recognize Topic 842’s cumulative effect within retained earnings in the period of adoption. In July 2017, the FASB issued ASU 2017-11, “Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features; (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception”, (ASU 2017-11). Part I of this update addresses the complexity of accounting for certain financial instruments with down round features. Down round features are features of certain equity-linked instruments (or embedded features) that result in the strike price being reduced on the basis of the pricing of future equity offerings. Current accounting guidance creates cost and complexity for entities that issue financial instruments (such as warrants and convertible instruments) with down round features that require fair value measurement of the entire instrument or conversion option. Part II of this update addresses the difficulty of navigating Topic 480, Distinguishing Liabilities from Equity, because of the existence of extensive pending content in the FASB Accounting Standards Codification. This pending content is the result of the indefinite deferral of accounting requirements about mandatorily redeemable financial instruments of certain nonpublic entities and certain mandatorily redeemable noncontrolling interests. The amendments in Part II of this update do not have an accounting effect. The amendments in Part I of ASU 2017-11 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other entities, the amendments in Part I are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. As the Company is an emerging growth company and elected to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act, this ASU 2017-11 will be effective for the Company beginning in fiscal 2020, although early adoption is permitted. The Company is currently assessing the potential impact of adopting ASU 2017-11 on its condensed consolidated financial statements and related disclosures. In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement”. The ASU modifies the disclosure requirements for fair value measurements by removing, modifying, or adding certain disclosures. This ASU is effective for the Company beginning in 2020. Early adoption is permitted. An entity is permitted to early adopt any removed or modified disclosures upon issuance of ASU No. 2018-13 and delay adoption of the additional disclosures until their effective date. The Company has not yet evaluated the impact of adoption of this ASU on its condensed consolidated financial statements disclosures.

The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands).   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="14" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value Measurements at March 31, 2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liabilities</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Series A warrant liability</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Series C warrant liability</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2017 PIPE warrant liability</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,274</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,274</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2018 PIPE warrant liability</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">784</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">784</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Essentialis purchase price contingency liability</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,855</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,855</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total common stock warrant and contingent <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   consideration liability</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,986</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,913</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="14" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value Measurements at December 31, 2018</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liabilities</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Series A warrant liability</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Series C warrant liability</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2017 PIPE warrant liability</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,563</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,563</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2018 PIPE warrant liability</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">600</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">600</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Essentialis purchase price contingency liability</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,649</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,649</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total common stock warrant and contingent <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   consideration liability</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,861</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,812</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>

The following table sets forth a summary of the changes in the fair value of the Company’s Level 1 and Level 3 warrants, which are treated as liabilities (dollars in thousands).   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:31.06%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series A Warrant</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Series C Warrant</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017 PIPE Warrants</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018 PIPE Warrants</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:5.9%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Purchase Price</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:31.06%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Warrants</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liability</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Warrants</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liability</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Warrants</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liability</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Warrants</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liability</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.9%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contingent <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liability</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.06%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2018</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">485,121</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,083</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,024,425</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,563</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">513,617</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">600</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,649</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.06%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in value of Series A Warrants</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.06%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in value of 2017 PIPE Warrants</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,711</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.06%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in value of 2018 PIPE Warrants</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">184</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:31.06%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in value of contingent liability</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">206</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:31.06%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at March 31, 2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">485,121</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,083</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,024,425</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,274</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">513,617</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">784</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:4.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,855</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>

The Company used the following inputs. <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March 31, <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Volatility</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contractual term (years)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.92</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.17</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free rate</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.41</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.60</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> </tr> </table></div>

The following summarizes certain key assumptions used in estimating the fair values. <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March 31, <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Volatility</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contractual term (years)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.7</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.0</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free rate</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.40</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.51</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> </tr> </table></div>

The following summarizes certain key assumptions used in estimating the fair values. <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March 31, <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Volatility</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contractual term (years)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.7</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.0</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free rate</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.23</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.51</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> </tr> </table></div>

There were no assets or liabilities held for sale as of March 31, 2019 or December 31, 2018 after the deconsolidation of Capnia in October 2018, and no discontinued operations during the three months ended March 31, 2019. The components of the Statements of Operations presented as Discontinued Operations during the three months ended March 31, 2018 follow (in thousands).   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product revenue</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of product revenue</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross profit (loss)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expenses</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">401</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales and marketing</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">102</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total expenses</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">514</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss from discontinued operations</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(514</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> </table></div>

Stock compensation expense was allocated between departments in continuing operations as follows (in thousands).   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended March 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">105</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">149</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">235</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">202</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">340</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>

The fair value of each award granted was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="4" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended March 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected life (years)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.0-6.1</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.0</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.6%</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.7%</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Volatility</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70%</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividend rate</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—  %</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—  %</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>

The following table summarizes stock option transactions for the three months ended March 31, 2019 as issued under the Plans:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares Available</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted- <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price per</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Term</td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">for Grant</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Share</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2018</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,150,961</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,667,153</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.03</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.27</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional shares authorized</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">223,742</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(464,000</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">464,000</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.67</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options canceled/forfeited</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,046</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,046</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.83</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at March 31, 2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">925,749</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,116,107</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.05</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.43</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options vested at March 31, 2019</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">901,140</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.14</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.52</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options vested and expected to vest at March 31, 2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,116,107</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.05</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.43</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>

The following potentially dilutive securities outstanding have been excluded from the computations of diluted weighted-average shares outstanding because such securities have an antidilutive impact due to losses reported (in common stock equivalent shares).   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of March 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Convertible preferred stock</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">714,200</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants issued to 2010/2012 convertible note <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   holders to purchase common stock</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">102,070</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">102,070</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options to purchase common stock</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,116,107</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,551,310</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants issued in 2009 to purchase common stock</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,851</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants issued to underwriter to purchase common stock</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,500</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,500</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Series A warrants to purchase common stock</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">485,121</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">485,121</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Series C warrants to purchase common stock</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,083</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,083</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Series D warrants to purchase common stock</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">586,162</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">586,182</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2017 PIPE warrants</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,024,425</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,024,425</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2018 PIPE warrants</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">513,617</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,962,085</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,599,742</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>

8000000

720000

18600000

10272375

1.61

16500000

0.05

2.00

513617

73000

6274000

784000

5855000 5855000

12986000

73000

12913000

49000

4563000

600000

5649000 5649000

10861000

49000

10812000

485121

49000

118083

6024425

4563000

513617

600000

5649000

24000

1711000

184000

206000

485121

73000

118083

6024425

6274000

513617

784000

5855000

489921

32.50

P5Y 0.01 4800

485121

24000

117902

32.50

6700000

3800000

31.25

2020-03-05 0.01

31.25

2020-03-05 181

6000

181

118083

0.90

P0Y11M1D

P1Y2M1D

0.0241

0.0260

2.00

1.72

6300000

1700000

0.86

0.75

P1Y8M12D

P2Y

0.0240

0.0251

10272375

0.05

2.00

784000

184000

0.86

0.75

P4Y8M12D

P5Y

0.0223

0.0251

0.00

P4Y

8171

23300

P3Y 5265

54000

85000

65000

98000

2200000

1.00

1200000 1200000 1200000

1690322

0.53

2000000

1.00

1480000

0.23

0.47

190000

51000 51000 401000 11000

102000

514000

-514000

19000

0.10

1.10

P4Y

P5Y

P10Y

925749

202000

359000

53000

105000

149000

235000

202000

340000

464000

616500

P6Y

P6Y1M6D

P6Y

0.026

0.027

0.71

0.70

0.00

1150961

223742

464000 0 15046

1667153

15046

2116107

901140

2116107

6.03

1.67

8.83

5.05

9.14

5.05

P8Y3M7D

P8Y5M4D

P7Y6M7D

P8Y5M4D

1.08

1.03

1500000

P2Y10M24D

476000

99217

1.00

159000

27967

0.010

55936

256064

586182

12.30

P5Y 2020-10-15 0.01

102070

24.35

P10Y 2024-11

16500

35.70

P10Y 2024-11

714200

102070

2116107

1551310

1851

16500

485121

118083

586162

586182

6024425

513617

9962085

9599742

30000000 4200000 1100000 5300000 2700000 2600000 5300000 1700000

-1700000

0.20 100000000 200000000 5900000 2600000

21415

49519

EX-101.SCH 7 slno-20190331.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document And Entity Information link:calculationLink link:presentationLink link:definitionLink 100010 - Statement - Condensed Consolidated Balance Sheets link:calculationLink link:presentationLink link:definitionLink 100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100030 - Statement - Condensed Consolidated Statements of Operations (unaudited) link:calculationLink link:presentationLink link:definitionLink 100040 - Statement - Condensed Consolidated Statements of Stockholders' Equity (unaudited) link:calculationLink link:presentationLink link:definitionLink 100050 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited) link:calculationLink link:presentationLink link:definitionLink 100060 - Disclosure - Overview link:calculationLink link:presentationLink link:definitionLink 100070 - Disclosure - Going Concern and Management's Plans link:calculationLink link:presentationLink link:definitionLink 100080 - Disclosure - Summary of Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 100090 - Disclosure - Fair Value of Financial Instruments link:calculationLink link:presentationLink link:definitionLink 100100 - Disclosure - Warrant Liabilities link:calculationLink link:presentationLink link:definitionLink 100110 - Disclosure - Commitments and Contingencies link:calculationLink link:presentationLink link:definitionLink 100120 - Disclosure - CoSense Joint Venture Agreement and Discontinued Operations link:calculationLink link:presentationLink link:definitionLink 100130 - Disclosure - Stockholders' Equity link:calculationLink link:presentationLink link:definitionLink 100140 - Disclosure - Net loss per share link:calculationLink link:presentationLink link:definitionLink 100150 - Disclosure - Fair Value of Contingent Consideration link:calculationLink link:presentationLink link:definitionLink 100160 - Disclosure - Compensation Plan for Board Members link:calculationLink link:presentationLink link:definitionLink 100170 - Disclosure - No Subsequent Events link:calculationLink link:presentationLink link:definitionLink 100180 - Disclosure - Summary of Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 100190 - Disclosure - Fair Value of Financial Instruments (Tables) link:calculationLink link:presentationLink link:definitionLink 100200 - Disclosure - Warrant Liabilities (Tables) link:calculationLink link:presentationLink link:definitionLink 100210 - Disclosure - CoSense Joint Venture Agreement and Discontinued Operations (Tables) link:calculationLink link:presentationLink link:definitionLink 100220 - Disclosure - Stockholders' Equity (Tables) link:calculationLink link:presentationLink link:definitionLink 100230 - Disclosure - Net loss per share (Tables) link:calculationLink link:presentationLink link:definitionLink 100240 - Disclosure - Overview - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100250 - Disclosure - Going Concern and Management's Plans - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100260 - Disclosure - Fair Value of Financial Instruments - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Detail) link:calculationLink link:presentationLink link:definitionLink 100270 - Disclosure - Fair Value of Financial Instruments - Summary of Changes in Fair Value of Level 1 and Level 3 Financial Instruments (Detail) link:calculationLink link:presentationLink link:definitionLink 100280 - Disclosure - Warrant Liabilities - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100290 - Disclosure - Warrant Liabilities - Fair Value of Convertible Preferred Stock Warrant Liability (Detail) link:calculationLink link:presentationLink link:definitionLink 100300 - Disclosure - Commitments and Contingencies - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100310 - Disclosure - CoSense Joint Venture Agreement and Discontinued Operations - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100320 - Disclosure - CoSense Joint Venture Agreement and Discontinued Operations - Components of Income of Discontinued Operations (Detail) link:calculationLink link:presentationLink link:definitionLink 100330 - Disclosure - Stockholders' Equity - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100340 - Disclosure - Stockholders' Equity - Summary of Stock Based Compensation Expense (Detail) link:calculationLink link:presentationLink link:definitionLink 100350 - Disclosure - Stockholders' Equity - Schedule of Fair Value of Award Granted Using Black-Scholes Option Pricing Model (Detail) link:calculationLink link:presentationLink link:definitionLink 100360 - Disclosure - Stockholders' Equity - Summary of Stock Option Transactions (Detail) link:calculationLink link:presentationLink link:definitionLink 100370 - Disclosure - Net loss per share - Schedule of Potentially Dilutive Securities Outstanding Excluded from Computations of Diluted Weighted-Average Shares Outstanding (Detail) link:calculationLink link:presentationLink link:definitionLink 100380 - Disclosure - Fair Value of Contingent Consideration - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100390 - Disclosure - Compensation Plan for Board Members - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 8 slno-20190331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 slno-20190331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 slno-20190331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Asset acquisition contingent consideration liability noncurrent. Document And Entity Information [Abstract] Document And Entity Information [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period Entity Common Stock Shares Outstanding Entity Common Stock Shares Outstanding Minority interest investment in subsidiary. Statement Of Financial Position [Abstract] Statement [Table] Statement [Table] Class of Warrant or Right Class Of Warrant Or Right [Axis] Class of Warrant or Right Class Of Warrant Or Right [Domain] Series A Warrants [Member] Series A Warrant Liability [Member] Series A Warrants [Member] 2017 PIPE warrant liability. 2017 PIPE Warrant Liability [Member] Two Thousand Seventeen P I P E Warrant Liability [Member] 2018 PIPE warrant liability. 2018 PIPE Warrant Liability [Member] Two Thousand Eighteen P I P E Warrant Liability [Member] Class of Stock Statement Class Of Stock [Axis] Class of Stock Class Of Stock [Domain] Series B Convertible Preferred Stock [Member] Series B Preferred Stock [Member] Statement [Line Items] Statement [Line Items] Assets Assets [Abstract] Current assets Assets Current [Abstract] Cash and cash equivalents Cash And Cash Equivalents At Carrying Value Prepaid expenses and other current assets Prepaid Expense And Other Assets Current Due from related party Due From Related Parties Current Minority interest investment in former subsidiary Minority Interest Investment In Subsidiary Total current assets Assets Current Long-term assets Assets Noncurrent [Abstract] Property and equipment, net Property Plant And Equipment Net Intangible assets, net Intangible Assets Net Excluding Goodwill Total assets Assets Liabilities and stockholders’ equity Liabilities And Stockholders Equity [Abstract] Current liabilities Liabilities Current [Abstract] Accounts payable Accounts Payable Current Accrued compensation and other current liabilities Accrued Liabilities And Other Liabilities Total current liabilities Liabilities Current Long-term liabilities Liabilities Noncurrent [Abstract] Warrant liability Derivative Liabilities Noncurrent Contingent liability for Essentialis purchase price Asset Acquisition Contingent Consideration Liability Noncurrent Total liabilities Liabilities Commitments and contingencies (Note 6) Commitments And Contingencies Stockholders’ equity Stockholders Equity [Abstract] Preferred stock Preferred Stock Value Common stock Common Stock Value Additional paid-in-capital Additional Paid In Capital Common Stock Accumulated deficit Retained Earnings Accumulated Deficit Total stockholders’ equity Stockholders Equity Total liabilities and stockholders’ equity Liabilities And Stockholders Equity Preferred stock par value (in dollars per share) Preferred Stock Par Or Stated Value Per Share Preferred stock shares authorized Preferred Stock Shares Authorized Preferred stock, shares issued Preferred Stock Shares Issued Preferred stock, shares outstanding Preferred Stock Shares Outstanding Preferred stock, aggregate liquidation preference Preferred Stock Liquidation Preference Value Common stock, par value (in dollars per share) Common Stock Par Or Stated Value Per Share Common stock, shares authorized Common Stock Shares Authorized Common stock, shares issued Common Stock Shares Issued Common stock, shares outstanding Common Stock Shares Outstanding Asset acquisition contingent consideration change in fair value. Income loss from minority interest investments. Income Statement [Abstract] Operating expenses Operating Expenses [Abstract] Research and development Research And Development Expense General and administrative General And Administrative Expense Change in fair value of contingent consideration Asset Acquisition Contingent Consideration Change In Fair Value Total operating expenses Operating Expenses Operating loss Operating Income Loss Other income (expense) Nonoperating Income Expense [Abstract] Cease-use income Gain Loss On Contract Termination Change in fair value of warrants liabilities Fair Value Adjustment Of Warrants Loss from minority interest investment Income Loss From Minority Interest Investments Interest income Other Nonoperating Income Expense Total other income (expense) Nonoperating Income Expense Loss from continuing operations Income Loss From Continuing Operations Loss from discontinued operations Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity Net loss Net Income Loss Loss per common share from continuing operations, basic and diluted Income Loss From Continuing Operations Per Basic And Diluted Share Loss per common share from discontinued operations, basic and diluted Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share Net loss per common share, basic and diluted Earnings Per Share Basic And Diluted Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share Weighted Average Number Of Share Outstanding Basic And Diluted Statement Of Stockholders Equity [Abstract] Equity Components Statement Equity Components [Axis] Equity Component Equity Component [Domain] Common Stock [Member] Common Stock [Member] Additional Paid-In Capital [Member] Additional Paid In Capital [Member] Accumulated Deficit [Member] Retained Earnings [Member] Asset purchase. Asset Purchase Asset Purchase [Axis] Asset purchase. Asset Purchase Asset Purchase [Domain] Essentialis, Inc. Essentialis, Inc. [Member] Essentialis Inc [Member] Balances at beginning Balances at beginning (shares) Shares Outstanding Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase Decrease In Stockholders Equity Roll Forward Stock-based compensation Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Issuance of common stock on conversion of series B convertible preferred shares Stock Issued During Period Value Conversion Of Convertible Securities Issuance of common stock on conversion of series B convertible preferred shares (shares) Stock Issued During Period Shares Conversion Of Convertible Securities Issuance of restricted common stock for bonuses Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures Issuance of restricted common stock for bonuses (shares) Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures Issuance of common stock to board members in lieu of cash payments for quarterly board fees Stock Issued During Period Value Issued For Services Issuance of common stock to board members in lieu of cash payments for quarterly board fees (shares) Stock Issued During Period Shares Issued For Services Transaction costs for common stock and warrant issuance. Adjustments To Additional Paid In Capital Stock Issued Issuance Costs Issuance of common stock held back on acquisition of Essentialis Stock Issued During Period Value Acquisitions Issuance of common stock held back on acquisition of Essentialis (Shares) Stock Issued During Period Shares Acquisitions Net loss Balances at ending Balances at end (shares) Cash paid for the issuance of common stock and common stock warrants. Cash and cash equivalents period increase decrease included in current assets held for sale. Accrued liability for cost of issuing common stock. Statement Of Cash Flows [Abstract] Operating Activities Statement Operating Activities Segment [Axis] Operating Activities Segment Operating Activities [Domain] Continuing Operations [Member] Segment Continuing Operations [Member] Discontinued Operations Segment Discontinued Operations [Member] Cash flows from operating activities: Net Cash Provided By Used In Operating Activities [Abstract] Net loss Profit Loss Loss from continuing operations Adjustments to reconcile net loss from continuing operations to net cash used in operating activities: Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Depreciation and amortization Depreciation And Amortization Stock-based compensation expense Share Based Compensation Board fees paid with common stock Other Noncash Expense Change in fair value of stock warrants Operating loss on minority interest investment Income Loss From Equity Method Investments Change in operating assets and liabilities: Increase Decrease In Operating Capital [Abstract] Prepaid expenses and other current assets Increase Decrease In Prepaid Deferred Expense And Other Assets Due from related party Increase Decrease In Due From Related Parties Accounts payable Increase Decrease In Accounts Payable Accrued compensation and other current liabilities Increase Decrease In Accrued Liabilities And Other Operating Liabilities Net cash used in continuing operating activities Net Cash Provided By Used In Operating Activities Continuing Operations Net cash used in discontinued operating activities Cash Provided By Used In Operating Activities Discontinued Operations Net cash used in operating activities Net Cash Provided By Used In Operating Activities Cash flows from investing activities: Net Cash Provided By Used In Investing Activities [Abstract] Purchases of property and equipment Payments To Acquire Property Plant And Equipment Net cash used in continuing investing activities Net Cash Provided By Used In Investing Activities Continuing Operations Net cash used in investing activities Net Cash Provided By Used In Investing Activities Cash flows from financing activities: Net Cash Provided By Used In Financing Activities [Abstract] Cash paid for the issuance of common stock and common stock warrants Cash Paid For The Issuance Of Common Stock And Common Stock Warrants Net cash used in continuing financing activities Net Cash Provided By Used In Financing Activities Continuing Operations Net cash provided by discontinued financing activities Cash Provided By Used In Financing Activities Discontinued Operations Net cash provided by financing activities Net Cash Provided By Used In Financing Activities Net decrease in cash, cash equivalents and restricted cash from continuing operations Cash And Cash Equivalents Period Increase Decrease Net decrease in cash, cash equivalents and restricted cash Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Net increase in cash and cash equivalents included in current assets held for sale Cash And Cash Equivalents Period Increase Decrease Included In Current Assets Held For Sale Cash, cash equivalents and restricted cash, beginning of period Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Cash, cash equivalents and restricted cash, end of period Supplemental disclosures of non-cash investing and financing information Noncash Investing And Financing Items [Abstract] Accrued liability for cost of issuing common stock Accrued Liability For Cost Of Issuing Common Stock Accounting Policies [Abstract] Overview Business Description And Basis Of Presentation [Text Block] Organization Consolidation And Presentation Of Financial Statements [Abstract] Going Concern and Management's Plans Substantial Doubt About Going Concern [Text Block] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Fair Value Disclosures [Abstract] Fair Value of Financial Instruments Fair Value Disclosures [Text Block] Warrant Liability Disclosure [Text Block] Text Block [Abstract] Warrant Liabilities Warrant Liability Disclosure [Text Block] Commitments And Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments And Contingencies Disclosure [Text Block] Discontinued Operations And Disposal Groups [Abstract] CoSense Joint Venture Agreement and Discontinued Operations Disposal Groups Including Discontinued Operations Disclosure [Text Block] Equity [Abstract] Stockholders' Equity Shareholders Equity And Share Based Payments [Text Block] Earnings Per Share [Abstract] Net loss per share Earnings Per Share [Text Block] Asset acquisitions. Fair Value of Contingent Consideration Asset Acquisitions Disclosure [Text Block] Compensation Related Costs [Abstract] Compensation Plan for Board Members Compensation Related Costs General [Text Block] Subsequent Events [Abstract] No Subsequent Events Subsequent Events [Text Block] Basis of Presentation Basis Of Accounting Policy Policy [Text Block] Recent Accounting Standards New Accounting Pronouncements Policy Policy [Text Block] Summary of Financial Instruments Measured at Fair Value on Recurring Basis Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Table [Text Block] Summary of Changes in Fair Value of Level1 and Level 3 Financial Instruments Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Text Block] Series C Warrants [Member] Series C Warrant [Member] Series C Warrants [Member] Fair Value of Convertible Preferred Stock Warrant Liability Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques Table [Text Block] Components of Discontinued Operations Schedule Of Disposal Groups Including Discontinued Operations Income Statement Balance Sheet And Additional Disclosures [Text Block] Summary of Stock Based Compensation Expense Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block] Schedule of Fair Value of Award Granted Using Black-Scholes Option Pricing Model Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block] Summary of Stock Option Transactions Schedule Of Share Based Compensation Stock Options Activity Table [Text Block] Schedule of Potentially Dilutive Securities Outstanding Excluded from Computations of Diluted Weighted-Average Shares Outstanding Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block] Asset acquisitions consideration transferred liabilities incurred. Schedule Of Stock By Class [Table] Schedule Of Stock By Class [Table] Disposal Group Name Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Axis] Disposal Group Name Disposal Groups Including Discontinued Operations Name [Domain] NeoForce Holdings Inc. NeoForce Holdings Inc. [Member] Neo Force Holdings Inc [Member] Class of Stock [Line Items] Class Of Stock [Line Items] Amount of financing needed Asset Acquisitions Consideration Transferred Liabilities Incurred Proceeds from the sale of business Proceeds From Divestiture Of Businesses Working Capital Liquidity And Managements Plans [Line Items] Liquidity And Managements Plans [Table] Liquidity And Managements Plans [Table] Liquidity And Managements Plans [Table] Antidilutive Securities Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis] Antidilutive Securities, Name Antidilutive Securities Name [Domain] Equity Unit Purchase Agreements [Member] Equity Unit Purchase Agreements [Member] Liquidity And Managements Plans [Line Items] Liquidity And Managements Plans [Line Items] Positive (deficit) in working capital Working Capital Net cash used in operating activities Proceeds from issuance or sale of equity gross. Number of newly issued Stock Issued During Period Shares New Issues Price per unit Shares Issued Price Per Share Gross Proceeds from issuance of units Proceeds From Issuance Or Sale Of Equity Gross Warrant to call common stock Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right Warrant exercise price Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Warrants, to purchase shares of common stock Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights EX-101.PRE 11 slno-20190331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	3 Months Ended
Document And Entity Information - shares	Mar. 31, 2019	May 06, 2019
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1
Trading Symbol	SLNO
Entity Registrant Name	SOLENO THERAPEUTICS INC
Entity Central Index Key	0001484565
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Common Stock Shares Outstanding		31,776,584

XML 13 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Current assets
Cash and cash equivalents	$ 19,402	$ 23,099
Prepaid expenses and other current assets	603	529
Due from related party	72	64
Minority interest investment in former subsidiary	788	978
Total current assets	20,865	24,670
Long-term assets
Property and equipment, net	19	12
Intangible assets, net	17,983	18,469
Total assets	38,867	43,151
Current liabilities
Accounts payable	1,258	934
Accrued compensation and other current liabilities	992	943
Total current liabilities	2,250	1,877
Long-term liabilities
Contingent liability for Essentialis purchase price	5,855	5,649
Total liabilities	15,236	12,738
Commitments and contingencies (Note 6)
Stockholders’ equity
Common stock	32	32
Additional paid-in-capital	157,661	157,413
Accumulated deficit	(134,062)	(127,032)
Total stockholders’ equity	23,631	30,413
Total liabilities and stockholders’ equity	38,867	43,151
Series B Convertible Preferred Stock [Member]
Stockholders’ equity
Preferred stock
Series A Warrant Liability [Member]
Long-term liabilities
Warrant liability	73	49
2017 PIPE Warrant Liability [Member]
Long-term liabilities
Warrant liability	6,274	4,563
2018 PIPE Warrant Liability [Member]
Long-term liabilities
Warrant liability	$ 784	$ 600

XML 14 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Preferred stock par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock shares authorized	10,000,000	10,000,000
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	31,776,584	31,755,169
Common stock, shares outstanding	31,776,584	31,755,169
Series B Convertible Preferred Stock [Member]
Preferred stock par value (in dollars per share)	$ 0.001
Preferred stock shares authorized	13,780	13,780
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Preferred stock, aggregate liquidation preference	$ 0	$ 0

XML 15 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Operations (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Operating expenses
Research and development	$ 2,760	$ 1,180
General and administrative	2,012	1,867
Change in fair value of contingent consideration	206	428
Total operating expenses	4,978	3,475
Operating loss	(4,978)	(3,475)
Other income (expense)
Cease-use income		3
Change in fair value of warrants liabilities	(1,919)	163
Loss from minority interest investment	(190)
Interest income	57	19
Total other income (expense)	(2,052)	185
Loss from continuing operations	(7,030)	(3,290)
Loss from discontinued operations		(514)
Net loss	$ (7,030)	$ (3,804)
Loss per common share from continuing operations, basic and diluted	$ (0.22)	$ (0.17)
Loss per common share from discontinued operations, basic and diluted		(0.02)
Net loss per common share, basic and diluted	$ (0.22)	$ (0.19)
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share	31,756,120	19,530,311

XML 16 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($) $ in Thousands	Total	2017 PIPE Warrant Liability [Member]	Series B Convertible Preferred Stock [Member]	Common Stock [Member]	Common Stock [Member] Essentialis, Inc. [Member]	Additional Paid-In Capital [Member]	Additional Paid-In Capital [Member] 2017 PIPE Warrant Liability [Member]	Accumulated Deficit [Member]
Balances at beginning at Dec. 31, 2017	$ 26,817			$ 19		$ 140,495		$ (113,697)
Balances at beginning (shares) at Dec. 31, 2017			4,571	19,238,972
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	200					200
Issuance of common stock on conversion of series B convertible preferred shares	1			$ 1
Issuance of common stock on conversion of series B convertible preferred shares (shares)			(1,000)	200,000
Issuance of restricted common stock for bonuses	159					159
Issuance of restricted common stock for bonuses (shares)				99,217
Issuance of common stock to board members in lieu of cash payments for quarterly board fees	82					82
Issuance of common stock to board members in lieu of cash payments for quarterly board fees (shares)				49,519
Transaction costs for common stock and warrant issuance.		$ (203)					$ (203)
Issuance of common stock held back on acquisition of Essentialis (Shares)					180,667
Net loss	(3,804)							(3,804)
Balances at ending at Mar. 31, 2018	23,252			$ 20		140,733		(117,501)
Balances at end (shares) at Mar. 31, 2018			3,571	19,768,375
Balances at beginning at Dec. 31, 2018	30,413			$ 32		157,413		(127,032)
Balances at beginning (shares) at Dec. 31, 2018				31,755,169
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	202					202
Issuance of common stock to board members in lieu of cash payments for quarterly board fees	46					46
Issuance of common stock to board members in lieu of cash payments for quarterly board fees (shares)				21,415
Net loss	(7,030)							(7,030)
Balances at ending at Mar. 31, 2019	$ 23,631			$ 32		$ 157,661		$ (134,062)
Balances at end (shares) at Mar. 31, 2019				31,776,584

XML 17 R6.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net loss	$ (7,030)	$ (3,804)
Loss from discontinued operations		(514)
Loss from continuing operations	(7,030)	(3,290)
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities:
Depreciation and amortization	489	492
Stock-based compensation expense	202	341
Board fees paid with common stock	46	82
Change in fair value of stock warrants	1,919	(163)
Change in fair value of contingent consideration	206	428
Operating loss on minority interest investment	190
Change in operating assets and liabilities:
Prepaid expenses and other current assets	(74)	(80)
Due from related party	(8)
Accounts payable	324	409
Accrued compensation and other current liabilities	49	(252)
Net cash used in continuing operating activities	(3,687)	(2,033)
Net cash used in discontinued operating activities		(487)
Net cash used in operating activities	(3,687)	(2,520)
Cash flows from investing activities:
Purchases of property and equipment	(10)
Net cash used in continuing investing activities	(10)
Net cash used in investing activities	(10)
Cash flows from financing activities:
Cash paid for the issuance of common stock and common stock warrants		(112)
Net cash used in continuing financing activities		(112)
Net cash provided by discontinued financing activities		400
Net cash provided by financing activities		288
Net decrease in cash, cash equivalents and restricted cash	(3,697)	(2,232)
Net increase in cash and cash equivalents included in current assets held for sale		(2)
Cash, cash equivalents and restricted cash, beginning of period	23,099	17,135
Cash, cash equivalents and restricted cash, end of period	19,402	14,901
Supplemental disclosures of non-cash investing and financing information
Accrued liability for cost of issuing common stock		91
Continuing Operations [Member]
Cash flows from financing activities:
Net decrease in cash, cash equivalents and restricted cash from continuing operations	$ (3,697)	(2,145)
Discontinued Operations
Cash flows from financing activities:
Net decrease in cash, cash equivalents and restricted cash from continuing operations		$ (87)

XML 18 R7.htm IDEA: XBRL DOCUMENT

Overview

3 Months Ended

Mar. 31, 2019

Accounting Policies [Abstract]

Overview

Note 1. Overview

XML 19 R8.htm IDEA: XBRL DOCUMENT

Going Concern and Management's Plans

3 Months Ended

Mar. 31, 2019

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Going Concern and Management's Plans

Note 2. Going Concern and Management’s Plans

XML 20 R9.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2019

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 3. Summary of Significant Accounting Policies

Basis of Presentation

Recent Accounting Standards

Recently Adopted Accounting Standards

In June 2018, the FASB issued ASU 2018-07, “Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting”, to simplify the accounting for share-based payments to nonemployees by aligning it with the accounting for share-based payments to employees, with certain exceptions. Under the guidance, the measurement of equity-classified nonemployee awards is fixed at the grant date, which may lower the cost and reduce volatility in the income statement. This ASU was early adopted by the Company at the beginning of 2019. Its adoption did not have a material impact on the Company’s condensed consolidated financial statements.

Recently Issued Accounting Standards

In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement”. The ASU modifies the disclosure requirements for fair value measurements by removing, modifying, or adding certain disclosures. This ASU is effective for the Company beginning in 2020. Early adoption is permitted. An entity is permitted to early adopt any removed or modified disclosures upon issuance of ASU No. 2018-13 and delay adoption of the additional disclosures until their effective date. The Company has not yet evaluated the impact of adoption of this ASU on its condensed consolidated financial statements disclosures.

XML 21 R10.htm IDEA: XBRL DOCUMENT

Fair Value of Financial Instruments

3 Months Ended

Mar. 31, 2019

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Note 4. Fair Value of Financial Instruments

The carrying value of the Company’s cash, restricted cash, cash equivalents and accounts payable, approximate fair value due to the short-term nature of these items.

The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:

•

Level I — Unadjusted quoted prices in active markets for identical assets or liabilities;

•

Level III — Unobservable inputs that are supported by little or no market activity for the related assets or liabilities.

The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands).

	Fair Value Measurements at March 31, 2019
	Total		Level 1		Level 2		Level 3
Liabilities
Series A warrant liability	$	73	$	73	$	—	$	—
Series C warrant liability		—		—		—		—
2017 PIPE warrant liability		6,274		—		—		6,274
2018 PIPE warrant liability		784		—		—		784
Essentialis purchase price contingency liability		5,855		—		—		5,855
Total common stock warrant and contingent consideration liability	$	12,986	$	73	$	—	$	12,913

	Fair Value Measurements at December 31, 2018
	Total		Level 1		Level 2		Level 3
Liabilities
Series A warrant liability	$	49	$	49	$	—	$	—
Series C warrant liability		—		—		—		—
2017 PIPE warrant liability		4,563		—		—		4,563
2018 PIPE warrant liability		600		—		—		600
Essentialis purchase price contingency liability		5,649		—		—		5,649
Total common stock warrant and contingent consideration liability	$	10,861	$	49	$	—	$	10,812

The Series A Warrant is a registered security that trades on the open market and the fair value of the Series A Warrant liability is based on the publicly quoted trading price of the warrants which is listed on and obtained from NASDAQ. Accordingly, the fair value of Series A Warrants is a Level 1 measurement. The fair value measurement of the Series C Warrants is based on significant inputs that are unobservable and thus represent Level 3 measurements. The Company’s estimated fair value of the Series C Warrant liability is calculated using the Black-Scholes valuation model, which is equivalent to fair value computed using the Binomial Lattice Option Model. Key assumptions include the volatility of the Company’s stock, the expected warrant term, expected dividend yield and risk-free interest rates. The Company’s estimated fair value of the 2017 PIPE Warrants and the 2018 PIPE Warrants was calculated using a Monte Carlo simulation of a geometric Brownian motion model. The Monte Carlo simulation pricing model requires the input of highly subjective assumptions including the expected stock price volatility, the expected term, the expected dividend yield and the risk-free interest rate. The fair value of the Essentialis purchase price contingent liability is estimated using scenario-based methods based upon the Company’s analysis of the likelihood of obtaining specified approvals from the Federal Drug Administration as well as reaching cumulative revenue milestones (see Note 10). The Level 3 estimates are based, in part, on subjective assumptions.

The following table sets forth a summary of the changes in the fair value of the Company’s Level 1 and Level 3 warrants, which are treated as liabilities (dollars in thousands).

	Series A Warrant				Series C Warrant				2017 PIPE Warrants				2018 PIPE Warrants				Purchase Price
	Number of Warrants		Liability		Number of Warrants		Liability		Number of Warrants		Liability		Number of Warrants		Liability		Contingent Liability
Balance at December 31, 2018		485,121	$	49		118,083	$	—		6,024,425	$	4,563		513,617	$	600	$	5,649
Change in value of Series A Warrants		—		24		—		—		—		—		—		—		—
Change in value of 2017 PIPE Warrants		—		—		—		—		—		1,711		—		—		—
Change in value of 2018 PIPE Warrants		—		—		—		—		—		—		—		184		—
Change in value of contingent liability		—		—		—		—		—		—		—		—		206
Balance at March 31, 2019		485,121	$	73		118,083	$	—		6,024,425	$	6,274		513,617	$	784	$	5,855

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 22 R11.htm IDEA: XBRL DOCUMENT

Warrant Liabilities

3 Months Ended

Mar. 31, 2019

Text Block [Abstract]

Warrant Liabilities

Note 5. Warrant Liabilities

Accounting Treatment

Series A Warrants

Series C Warrants

	March 31, 2019			December 31, 2018
Volatility		90	%		90	%
Contractual term (years)		0.92			1.17
Expected dividend yield		—	%		—	%
Risk-free rate		2.41	%		2.60	%

Warrants Issued as Part of the Units in the 2017 PIPE Offering

	March 31, 2019			December 31, 2018
Volatility		86	%		75	%
Contractual term (years)		1.7			2.0
Expected dividend yield		—	%		—	%
Risk-free rate		2.40	%		2.51	%

Warrants Issued as Part of the Units in the 2018 PIPE Offering

	March 31, 2019			December 31, 2018
Volatility		86	%		75	%
Contractual term (years)		4.7			5.0
Expected dividend yield		—	%		—	%
Risk-free rate		2.23	%		2.51	%

•

Volatility: The Company calculates the estimated volatility rate based on the volatilities of common stock of comparable companies in its industry.

•

Contractual term: The expected life of the warrants, which is based on the contractual term of the warrants.

•

Risk-free rate: The risk-free interest rate is based on the U.S. Treasury rate for similar periods as those of expected volatility.

XML 23 R12.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

3 Months Ended

Mar. 31, 2019

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 6. Commitments and Contingencies

Facility Leases

Rent expense was approximately $54,000 and $85,000 during the three months ended March 31, 2019 and 2018, respectively, net of sublease income of approximately $65,000 and $98,000, respectively.

Contingencies

XML 24 R13.htm IDEA: XBRL DOCUMENT

CoSense Joint Venture Agreement and Discontinued Operations

3 Months Ended

Mar. 31, 2019

Discontinued Operations And Disposal Groups [Abstract]

CoSense Joint Venture Agreement and Discontinued Operations

Note 7. CoSense Joint Venture Agreement and Discontinued Operations


Product revenue	$	51
Cost of product revenue		51
Gross profit (loss)		—
Expenses
Research and development		401
Sales and marketing		11
General and administrative		102
Total expenses		514
Net loss from discontinued operations	$	(514	)

XML 25 R14.htm IDEA: XBRL DOCUMENT

Stockholders' Equity

3 Months Ended

Mar. 31, 2019

Equity [Abstract]

Stockholders' Equity

Note 8. Stockholders’ Equity

Equity Incentive Plans

Stock compensation expense was allocated between departments in continuing operations as follows (in thousands).

	Three Months Ended March 31,
	2019		2018
Research and development	$	53	$	105
General and administrative		149		235
Total	$	202	$	340

Stock Options

	Three Months Ended March 31,
	2019	2018
Expected life (years)	6.0-6.1	6.0
Risk-free interest rate	2.6%	2.7%
Volatility	71%	70%
Dividend rate	— %	— %

The Black-Scholes option-pricing model requires the use of highly subjective assumptions to estimate the fair value of stock-based awards. These assumptions include the following estimates:

•

Risk-free interest rate: The risk-free interest rate is based on the yields of U.S. Treasury securities with maturities similar to the expected time to liquidity.

•

Volatility: The estimated volatility rate based on the volatilities of common stock of comparable companies in the Company’s industry.

•

The following table summarizes stock option transactions for the three months ended March 31, 2019 as issued under the Plans:

	Shares Available			Number of Options			Weighted- Average Exercise Price per		Weighted Average Remaining Contractual Term
	for Grant			Outstanding			Share		(in years)
Balance at December 31, 2018		1,150,961			1,667,153		$	6.03		8.27
Additional shares authorized		223,742
Options granted		(464,000	)		464,000		$	1.67
Options exercised		—			—			—		—
Options canceled/forfeited		15,046			(15,046	)	$	8.83		—
Balance at March 31, 2019		925,749			2,116,107		$	5.05		8.43
Options vested at March 31, 2019					901,140		$	9.14		7.52
Options vested and expected to vest at March 31, 2019					2,116,107		$	5.05		8.43

Restricted Stock Units

2014 Employee Stock Purchase Plan

•

1.0% of the outstanding shares of the Company’s common stock on the first day of such year;

•

55,936 shares; or

•

such amount as determined by the board of directors.

As of March 31, 2019, there were no purchases by employees under this plan.

Series D Warrants

Accounting Treatment

Other Common Stock Warrants

XML 26 R15.htm IDEA: XBRL DOCUMENT

Net loss per share

3 Months Ended

Mar. 31, 2019

Earnings Per Share [Abstract]

Net loss per share

Note 9. Net loss per share

	As of March 31,
	2019		2018
Convertible preferred stock		—		714,200
Warrants issued to 2010/2012 convertible note holders to purchase common stock		102,070		102,070
Options to purchase common stock		2,116,107		1,551,310
Warrants issued in 2009 to purchase common stock		—		1,851
Warrants issued to underwriter to purchase common stock		16,500		16,500
Series A warrants to purchase common stock		485,121		485,121
Series C warrants to purchase common stock		118,083		118,083
Series D warrants to purchase common stock		586,162		586,182
2017 PIPE warrants		6,024,425		6,024,425
2018 PIPE warrants		513,617		—
Total		9,962,085		9,599,742

XML 27 R16.htm IDEA: XBRL DOCUMENT

Fair Value of Contingent Consideration

3 Months Ended

Mar. 31, 2019

Text Block [Abstract]

Fair Value of Contingent Consideration

Note 10. Fair Value of Contingent Consideration

XML 28 R17.htm IDEA: XBRL DOCUMENT

Compensation Plan for Board Members

3 Months Ended

Mar. 31, 2019

Compensation Plan for Board Members

Note 11. Compensation Plan for Board Members

XML 29 R18.htm IDEA: XBRL DOCUMENT

No Subsequent Events

3 Months Ended

Mar. 31, 2019

Subsequent Events [Abstract]

No Subsequent Events

Note 12. No Subsequent Events

XML 30 R19.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Policies)	3 Months Ended
Summary of Significant Accounting Policies (Policies)	Mar. 31, 2019
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP, and the applicable rules and regulations of the SEC for interim financial information. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. The condensed consolidated balance sheet at December 31, 2018, has been derived from the audited consolidated financial statements at that date, but does not include all disclosures, including notes, required by GAAP for complete financial statements. The unaudited interim condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, reflect all adjustments of a normal recurring nature that are necessary for a fair presentation of the results for the interim periods presented. The interim results are not necessarily indicative of the results for any future interim period or for the entire year. The accompanying condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the related notes thereto for the year ended December 31, 2018, included in the Company’s Annual Report on Form 10-K.
Recent Accounting Standards	Recent Accounting Standards Recently Adopted Accounting Standards In June 2018, the FASB issued ASU 2018-07, “Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting”, to simplify the accounting for share-based payments to nonemployees by aligning it with the accounting for share-based payments to employees, with certain exceptions. Under the guidance, the measurement of equity-classified nonemployee awards is fixed at the grant date, which may lower the cost and reduce volatility in the income statement. This ASU was early adopted by the Company at the beginning of 2019. Its adoption did not have a material impact on the Company’s condensed consolidated financial statements. In August 2018, SEC adopted the final rule under SEC Release No. 33-10532, “Disclosure Update and Simplification”, amending certain disclosure requirements that were redundant, duplicative, overlapping, outdated or superseded. In addition, the amendments expanded the disclosure requirements on the analysis of stockholders’ equity for interim financial statements. Under the amendments, an analysis of changes in each caption of stockholders’ equity presented in the balance sheet must now be provided in a note or separate statement. The Company has applied this new guidance to its condensed financial statements for the first quarter of 2019. Recently Issued Accounting Standards In February 2016, the FASB issued ASU 2016-02: “Leases (Topic 842)”. ASU 2016-02 provides new comprehensive lease accounting guidance that supersedes existing lease guidance. Upon adoption of ASU 2016-02, the Company may elect to apply the transition approach either as of the beginning of the earliest period presented in the financial statements – in which case it would restate its comparative periods, or as of the beginning of the period of adoption – in which case it would not restate its comparative periods. ASU 2016-02 requires the Company to capitalize most current operating lease obligations as right-of-use assets with a corresponding liability based on the present value of future operating lease obligations. Criteria for distinguishing leases between finance and operating are substantially similar to criteria for distinguishing between capital leases and operating leases in existing lease guidance. Lease agreements that are 12 months or less are permitted to be excluded from the balance sheet. Topic 842 includes a number of optional practical expedients that the Company may elect to apply. Expanded disclosures with additional qualitative and quantitative information will also be required. The adoption will include updates as provided under ASU 2018-01, Leases (Topic 842): Land Easement Practical Expedient for Transition to Topic 842, ASU 2018-10, Codification Improvements to Topic 842, Leases, ASU 2018-20, Leases (Topic 842): Narrow-Scope Improvements for Lessors and ASU 2019-01, Leases (Topic 842): Codification Improvements. Topic 842 is effective for public entities with fiscal years beginning after December 15, 2018 and for all other entities for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. As the Company is an emerging growth company and elected to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act, Topic 842 will be effective for the Company beginning in fiscal 2020, although early adoption is permitted. The Company is currently evaluating the potential impact of adoption of this standard on its condensed consolidated financial statements and the additional transition method under ASU 2018-11, which allows the Company to recognize Topic 842’s cumulative effect within retained earnings in the period of adoption. In July 2017, the FASB issued ASU 2017-11, “Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features; (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception”, (ASU 2017-11). Part I of this update addresses the complexity of accounting for certain financial instruments with down round features. Down round features are features of certain equity-linked instruments (or embedded features) that result in the strike price being reduced on the basis of the pricing of future equity offerings. Current accounting guidance creates cost and complexity for entities that issue financial instruments (such as warrants and convertible instruments) with down round features that require fair value measurement of the entire instrument or conversion option. Part II of this update addresses the difficulty of navigating Topic 480, Distinguishing Liabilities from Equity, because of the existence of extensive pending content in the FASB Accounting Standards Codification. This pending content is the result of the indefinite deferral of accounting requirements about mandatorily redeemable financial instruments of certain nonpublic entities and certain mandatorily redeemable noncontrolling interests. The amendments in Part II of this update do not have an accounting effect. The amendments in Part I of ASU 2017-11 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other entities, the amendments in Part I are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. As the Company is an emerging growth company and elected to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act, this ASU 2017-11 will be effective for the Company beginning in fiscal 2020, although early adoption is permitted. The Company is currently assessing the potential impact of adopting ASU 2017-11 on its condensed consolidated financial statements and related disclosures. In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement”. The ASU modifies the disclosure requirements for fair value measurements by removing, modifying, or adding certain disclosures. This ASU is effective for the Company beginning in 2020. Early adoption is permitted. An entity is permitted to early adopt any removed or modified disclosures upon issuance of ASU No. 2018-13 and delay adoption of the additional disclosures until their effective date. The Company has not yet evaluated the impact of adoption of this ASU on its condensed consolidated financial statements disclosures.

XML 31 R20.htm IDEA: XBRL DOCUMENT

Fair Value of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2019

Fair Value Disclosures [Abstract]

Summary of Financial Instruments Measured at Fair Value on Recurring Basis

The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands).

	Fair Value Measurements at March 31, 2019
	Total		Level 1		Level 2		Level 3
Liabilities
Series A warrant liability	$	73	$	73	$	—	$	—
Series C warrant liability		—		—		—		—
2017 PIPE warrant liability		6,274		—		—		6,274
2018 PIPE warrant liability		784		—		—		784
Essentialis purchase price contingency liability		5,855		—		—		5,855
Total common stock warrant and contingent consideration liability	$	12,986	$	73	$	—	$	12,913

	Fair Value Measurements at December 31, 2018
	Total		Level 1		Level 2		Level 3
Liabilities
Series A warrant liability	$	49	$	49	$	—	$	—
Series C warrant liability		—		—		—		—
2017 PIPE warrant liability		4,563		—		—		4,563
2018 PIPE warrant liability		600		—		—		600
Essentialis purchase price contingency liability		5,649		—		—		5,649
Total common stock warrant and contingent consideration liability	$	10,861	$	49	$	—	$	10,812

Summary of Changes in Fair Value of Level1 and Level 3 Financial Instruments

The following table sets forth a summary of the changes in the fair value of the Company’s Level 1 and Level 3 warrants, which are treated as liabilities (dollars in thousands).

	Series A Warrant				Series C Warrant				2017 PIPE Warrants				2018 PIPE Warrants				Purchase Price
	Number of Warrants		Liability		Number of Warrants		Liability		Number of Warrants		Liability		Number of Warrants		Liability		Contingent Liability
Balance at December 31, 2018		485,121	$	49		118,083	$	—		6,024,425	$	4,563		513,617	$	600	$	5,649
Change in value of Series A Warrants		—		24		—		—		—		—		—		—		—
Change in value of 2017 PIPE Warrants		—		—		—		—		—		1,711		—		—		—
Change in value of 2018 PIPE Warrants		—		—		—		—		—		—		—		184		—
Change in value of contingent liability		—		—		—		—		—		—		—		—		206
Balance at March 31, 2019		485,121	$	73		118,083	$	—		6,024,425	$	6,274		513,617	$	784	$	5,855

- Definition

Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.

+ References + Details

XML 32 R21.htm IDEA: XBRL DOCUMENT

Warrant Liabilities (Tables)

3 Months Ended

Mar. 31, 2019

Series C Warrant [Member]

Fair Value of Convertible Preferred Stock Warrant Liability

The Company used the following inputs.

	March 31, 2019			December 31, 2018
Volatility		90	%		90	%
Contractual term (years)		0.92			1.17
Expected dividend yield		—	%		—	%
Risk-free rate		2.41	%		2.60	%

2017 PIPE Warrant Liability [Member]

Fair Value of Convertible Preferred Stock Warrant Liability

The following summarizes certain key assumptions used in estimating the fair values.

	March 31, 2019			December 31, 2018
Volatility		86	%		75	%
Contractual term (years)		1.7			2.0
Expected dividend yield		—	%		—	%
Risk-free rate		2.40	%		2.51	%

2018 PIPE Warrant Liability [Member]

Fair Value of Convertible Preferred Stock Warrant Liability

The following summarizes certain key assumptions used in estimating the fair values.

	March 31, 2019			December 31, 2018
Volatility		86	%		75	%
Contractual term (years)		4.7			5.0
Expected dividend yield		—	%		—	%
Risk-free rate		2.23	%		2.51	%

XML 33 R22.htm IDEA: XBRL DOCUMENT

CoSense Joint Venture Agreement and Discontinued Operations (Tables)

3 Months Ended

Mar. 31, 2019

Discontinued Operations And Disposal Groups [Abstract]

Components of Discontinued Operations


Product revenue	$	51
Cost of product revenue		51
Gross profit (loss)		—
Expenses
Research and development		401
Sales and marketing		11
General and administrative		102
Total expenses		514
Net loss from discontinued operations	$	(514	)

- Definition

Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5D
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5C
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5A
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5B
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760

+ Details

XML 34 R23.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2019

Equity [Abstract]

Summary of Stock Based Compensation Expense

Stock compensation expense was allocated between departments in continuing operations as follows (in thousands).

	Three Months Ended March 31,
	2019		2018
Research and development	$	53	$	105
General and administrative		149		235
Total	$	202	$	340

Schedule of Fair Value of Award Granted Using Black-Scholes Option Pricing Model

The fair value of each award granted was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions

	Three Months Ended March 31,
	2019	2018
Expected life (years)	6.0-6.1	6.0
Risk-free interest rate	2.6%	2.7%
Volatility	71%	70%
Dividend rate	— %	— %

Summary of Stock Option Transactions

The following table summarizes stock option transactions for the three months ended March 31, 2019 as issued under the Plans:

	Shares Available			Number of Options			Weighted- Average Exercise Price per		Weighted Average Remaining Contractual Term
	for Grant			Outstanding			Share		(in years)
Balance at December 31, 2018		1,150,961			1,667,153		$	6.03		8.27
Additional shares authorized		223,742
Options granted		(464,000	)		464,000		$	1.67
Options exercised		—			—			—		—
Options canceled/forfeited		15,046			(15,046	)	$	8.83		—
Balance at March 31, 2019		925,749			2,116,107		$	5.05		8.43
Options vested at March 31, 2019					901,140		$	9.14		7.52
Options vested and expected to vest at March 31, 2019					2,116,107		$	5.05		8.43

XML 35 R24.htm IDEA: XBRL DOCUMENT

Net loss per share (Tables)

3 Months Ended

Mar. 31, 2019

Earnings Per Share [Abstract]

Schedule of Potentially Dilutive Securities Outstanding Excluded from Computations of Diluted Weighted-Average Shares Outstanding

	As of March 31,
	2019		2018
Convertible preferred stock		—		714,200
Warrants issued to 2010/2012 convertible note holders to purchase common stock		102,070		102,070
Options to purchase common stock		2,116,107		1,551,310
Warrants issued in 2009 to purchase common stock		—		1,851
Warrants issued to underwriter to purchase common stock		16,500		16,500
Series A warrants to purchase common stock		485,121		485,121
Series C warrants to purchase common stock		118,083		118,083
Series D warrants to purchase common stock		586,162		586,182
2017 PIPE warrants		6,024,425		6,024,425
2018 PIPE warrants		513,617		—
Total		9,962,085		9,599,742

XML 36 R25.htm IDEA: XBRL DOCUMENT

Overview - Additional Information (Detail) - USD ($)	Jul. 18, 2017	Dec. 22, 2016
NeoForce Holdings Inc. [Member]
Class of Stock [Line Items]
Proceeds from the sale of business	$ 720,000
Essentialis, Inc. [Member]
Class of Stock [Line Items]
Amount of financing needed		$ 8,000,000

XML 37 R26.htm IDEA: XBRL DOCUMENT

Going Concern and Management's Plans - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
	Dec. 19, 2018	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Liquidity And Managements Plans [Line Items]
Net loss		$ (7,030)	$ (3,804)
Accumulated deficit		(134,062)		$ (127,032)
Positive (deficit) in working capital		18,600
Net cash used in operating activities		$ (3,687)	$ (2,520)
Equity Unit Purchase Agreements [Member]
Liquidity And Managements Plans [Line Items]
Number of newly issued	10,272,375
Price per unit	$ 1.61
Gross Proceeds from issuance of units	$ 16,500
Common Stock [Member] \| Equity Unit Purchase Agreements [Member]
Liquidity And Managements Plans [Line Items]
Warrant to call common stock	0.05
Warrant exercise price	$ 2.00
Warrants, to purchase shares of common stock	513,617

XML 38 R27.htm IDEA: XBRL DOCUMENT

Fair Value of Financial Instruments - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Detail) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Liabilities
Contingent liability for Essentialis purchase price	$ 5,855,000	$ 5,649,000
Series A Warrant Liability [Member]
Liabilities
Warrant liability	73,000	49,000
Series C Warrant [Member]
Liabilities
Warrant liability	0
2017 PIPE Warrant Liability [Member]
Liabilities
Warrant liability	6,274,000	4,563,000
2018 PIPE Warrant Liability [Member]
Liabilities
Warrant liability	784,000	600,000
Fair Value, Measurements, Recurring [Member]
Liabilities
Total common stock warrant and contingent consideration liability	12,986,000	10,861,000
Fair Value, Measurements, Recurring [Member] \| Convertible preferred stock warrant liability [Member] \| Series A Warrant Liability [Member]
Liabilities
Warrant liability	73,000	49,000
Fair Value, Measurements, Recurring [Member] \| Convertible preferred stock warrant liability [Member] \| 2017 PIPE Warrant Liability [Member]
Liabilities
Warrant liability	6,274,000	4,563,000
Fair Value, Measurements, Recurring [Member] \| Convertible preferred stock warrant liability [Member] \| 2018 PIPE Warrant Liability [Member]
Liabilities
Warrant liability	784,000	600,000
Essentialis, Inc. [Member] \| Fair Value, Measurements, Recurring [Member]
Liabilities
Contingent liability for Essentialis purchase price	5,855,000	5,649,000
Level 1 [Member] \| Fair Value, Measurements, Recurring [Member]
Liabilities
Total common stock warrant and contingent consideration liability	73,000	49,000
Level 1 [Member] \| Fair Value, Measurements, Recurring [Member] \| Convertible preferred stock warrant liability [Member] \| Series A Warrant Liability [Member]
Liabilities
Warrant liability	73,000	49,000
Level 3 [Member] \| Fair Value, Measurements, Recurring [Member]
Liabilities
Total common stock warrant and contingent consideration liability	12,913,000	10,812,000
Level 3 [Member] \| Fair Value, Measurements, Recurring [Member] \| Convertible preferred stock warrant liability [Member] \| 2017 PIPE Warrant Liability [Member]
Liabilities
Warrant liability	6,274,000	4,563,000
Level 3 [Member] \| Fair Value, Measurements, Recurring [Member] \| Convertible preferred stock warrant liability [Member] \| 2018 PIPE Warrant Liability [Member]
Liabilities
Warrant liability	784,000	600,000
Level 3 [Member] \| Essentialis, Inc. [Member] \| Fair Value, Measurements, Recurring [Member]
Liabilities
Contingent liability for Essentialis purchase price	$ 5,855,000	$ 5,649,000

XML 39 R28.htm IDEA: XBRL DOCUMENT

Fair Value of Financial Instruments - Summary of Changes in Fair Value of Level 1 and Level 3 Financial Instruments (Detail) $ in Thousands	3 Months Ended
	Mar. 31, 2019 USD ($) shares
Purchase price contingent liability [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at the beginning of period	$ 5,649
Change in value of liabilities	206
Balance at end of period	$ 5,855
Series A Warrant Liability [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at the end of period, in shares \| shares	485,121
Series A Warrant Liability [Member] \| Common stock warrant liability [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at the beginning of period	$ 49
Balance at the beginning of period, in shares \| shares	485,121
Change in value of liabilities	$ 24
Balance at end of period	$ 73
Balance at the end of period, in shares \| shares	485,121
Series C Warrant [Member] \| Common stock warrant liability [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at the beginning of period, in shares \| shares	118,083
Balance at the end of period, in shares \| shares	118,083
2017 PIPE Warrant Liability [Member] \| Common stock warrant liability [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at the beginning of period	$ 4,563
Balance at the beginning of period, in shares \| shares	6,024,425
Change in value of liabilities	$ 1,711
Balance at end of period	$ 6,274
Balance at the end of period, in shares \| shares	6,024,425
2018 PIPE Warrant Liability [Member] \| Common stock warrant liability [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at the beginning of period	$ 600
Balance at the beginning of period, in shares \| shares	513,617
Change in value of liabilities	$ 184
Balance at end of period	$ 784
Balance at the end of period, in shares \| shares	513,617

XML 40 R29.htm IDEA: XBRL DOCUMENT

Warrant Liabilities - Additional Information (Detail)			1 Months Ended	3 Months Ended
Warrant Liabilities - Additional Information (Detail)	Apr. 30, 2015 $ / shares	Mar. 05, 2015 USD ($) $ / shares shares	Jul. 31, 2015 USD ($) shares	Mar. 31, 2019 USD ($) $ / shares shares	Mar. 31, 2018 USD ($)	Dec. 31, 2018 USD ($)	Dec. 19, 2018 $ / shares shares	Dec. 15, 2017 $ / shares shares
Class Of Warrant Or Right [Line Items]
Change in fair value of stock warrants				$ 1,919,000	$ (163,000)
Expected Dividend Yield [Member]
Class Of Warrant Or Right [Line Items]
Measurement input				0.00
Series A Warrants to Purchase Shares of Common Stock [Member] \| IPO [Member]
Class Of Warrant Or Right [Line Items]
Number of common stock purchased upon issuance of warrants \| shares				489,921
Exercise price of warrants exercised \| $ / shares				$ 32.50
Warrants term				5 years
Series A Warrant Liability [Member]
Class Of Warrant Or Right [Line Items]
Aggregate VWAP (percent)				1.00%
Warrants exercised (in shares) \| shares				4,800
Warrants outstanding (in shares) \| shares				485,121
Warrant liability				$ 73,000		$ 49,000
Change in fair value of stock warrants				$ 24,000
Series B Warrant Liability [Member]
Class Of Warrant Or Right [Line Items]
Exercise price of warrants exercised \| $ / shares		$ 32.50
Warrants exercised (in shares) \| shares		117,902
De-recognition of warrant liability		$ 6,700,000
Proceeds from exercise of warrants		$ 3,800,000
Series C Warrant [Member]
Class Of Warrant Or Right [Line Items]
Number of common stock purchased upon issuance of warrants \| shares				118,083
Exercise price of warrants exercised \| $ / shares	$ 31.25	$ 31.25
Aggregate VWAP (percent)				1.00%
Warrant liability				$ 0
Tender offer expiration date	Mar. 05, 2020	Mar. 05, 2020
Proceeds from issuance of common stock under tender offer			$ 6,000
Warrants cashless exercised (in shares) \| shares			181
Series C Warrant [Member] \| Common Stock [Member]
Class Of Warrant Or Right [Line Items]
Issuance of shares upon cashless exercise warrants (in shares) \| shares			181
2017 PIPE Warrant Liability [Member]
Class Of Warrant Or Right [Line Items]
Number of common stock purchased upon issuance of warrants \| shares								1
Exercise price of warrants exercised \| $ / shares								$ 2.00
Warrant liability				6,274,000		4,563,000
Change in fair value of stock warrants				$ 1,700,000
Warrant issuance description				The 2017 PIPE Warrants were issued on December 15, 2017 in the 2017 PIPE Offering, pursuant to a Warrant Agreement with each of the investors in the 2017 PIPE Offering, and entitle the holder to purchase one share of the Company’s common stock at an exercise price equal to $2.00 per share, subject to adjustment as discussed below, at any time commencing upon issuance of the 2017 PIPE Warrants and terminating at the earlier of December 15, 2020 or 30 days following positive Phase III results for the DCCR tablet in PWS.
Fair value of estimated warrants				$ 6,300,000
2017 PIPE Warrant Liability to Purchase Common Stock [Member] \| Minimum [Member]
Class Of Warrant Or Right [Line Items]
Exercise price of warrants exercised \| $ / shares				$ 1.72
2018 PIPE Warrant Liability [Member]
Class Of Warrant Or Right [Line Items]
Number of common stock purchased upon issuance of warrants \| shares							10,272,375
Exercise price of warrants exercised \| $ / shares							$ 2.00
Warrant liability				$ 784,000		$ 600,000
Change in fair value of stock warrants				$ 184,000
Warrant issuance description				The 2018 PIPE Warrants were issued on December 19, 2018 in the 2018 PIPE Offering, pursuant to a Warrant Agreement with each of the investors in the 2018 PIPE Offering, and entitle the holders of each of the 10,272,375 units to purchase 0.05 shares of the Company’s common stock at an exercise price equal to $2.00 per share, subject to adjustment as discussed below, at any time commencing upon issuance of the 2018 PIPE Warrants and terminating on December 21, 2023.
Fair value of estimated warrants				$ 784,000
Warrant to call common stock \| shares							0.05
2018 PIPE Warrant Liability [Member] \| Minimum [Member]
Class Of Warrant Or Right [Line Items]
Exercise price of warrants exercised \| $ / shares				$ 2.00

XML 41 R30.htm IDEA: XBRL DOCUMENT

Warrant Liabilities - Fair Value of Convertible Preferred Stock Warrant Liability (Detail)	Mar. 31, 2019	Dec. 31, 2018
Expected Dividend Yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.00
Series C Warrant [Member] \| Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.90	0.90
Series C Warrant [Member] \| Contractual Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement term	11 months 1 day	1 year 2 months 1 day
Series C Warrant [Member] \| Risk-free Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.0241	0.0260
2017 PIPE Warrant Liability [Member] \| Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.86	0.75
2017 PIPE Warrant Liability [Member] \| Contractual Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement term	1 year 8 months 12 days	2 years
2017 PIPE Warrant Liability [Member] \| Risk-free Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.0240	0.0251
2018 PIPE Warrant Liability [Member] \| Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.86	0.75
2018 PIPE Warrant Liability [Member] \| Contractual Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement term	4 years 8 months 12 days	5 years
2018 PIPE Warrant Liability [Member] \| Risk-free Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.0223	0.0251

XML 42 R31.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies - Additional Information (Detail)			3 Months Ended
	Mar. 01, 2016 ft²	Jul. 01, 2015 USD ($) ft²	Mar. 31, 2019 USD ($)	Mar. 31, 2018 USD ($)
Commitments And Contingencies Disclosure [Abstract]
Non-cancelable operating lease agreement term		4 years
Area of real estate property (in sqft) \| ft²		8,171
Future minimum commitment under non-cancelable operating lease		$ 23,300
Period of increases to monthly payments		3 years
Additional area of office space for headquarters facility \| ft²	5,265
Rent expense			$ 54,000	$ 85,000
Sublease income			$ 65,000	$ 98,000

XML 43 R32.htm IDEA: XBRL DOCUMENT

CoSense Joint Venture Agreement and Discontinued Operations - Additional Information (Detail)		3 Months Ended
	Oct. 16, 2018 shares	Mar. 31, 2019 USD ($) $ / shares shares	Dec. 31, 2018 USD ($)	Mar. 31, 2018 USD ($)	Sep. 30, 2018 USD ($)	Dec. 31, 2017 USD ($) $ / shares
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Current period gain recognized			$ 2,000,000
Loss from discontinued operations				$ (514,000)
Stock-based compensation expense		$ 202,000		359,000
Discontinued Operations, Held-for-sale [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Stock-based compensation expense		0		19,000
CoSense, NFI and Serenz [Member] \| Discontinued Operations, Held-for-sale [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets held for sale, current		0	0
Assets held for sale, long-term		0	0
Liabilities held for sale, current		0	0
Liabilities held for sale, long-term		0	$ 0
Loss from discontinued operations		$ 0		$ (514,000)
Capnia Inc Joint Venture [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Negotiated price per share \| $ / shares		$ 1.00
Percentage of ownership interest		47.00%
Number of shares owned \| shares		1,480,000
Percentage of discount for lack of control		0.23
Drcrease in minority interest investment		$ (190,000)
OAHL [Member] \| Capnia Inc Joint Venture [Member] \| Corporate Joint Venture [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Investment threshold requirement						$ 2,200,000
Negotiated price per share \| $ / shares						$ 1.00
Investment threshold requirement stock issuance		$ 1,200,000			$ 1,200,000	$ 1,200,000
Issuance of common stock (shares) \| shares	1,690,322
Percentage of ownership interest	53.00%

XML 44 R33.htm IDEA: XBRL DOCUMENT

CoSense Joint Venture Agreement and Discontinued Operations - Components of Income of Discontinued Operations (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Expenses
Net loss from discontinued operations		$ (514,000)
CoSense, NFI and Serenz [Member] \| Discontinued Operations, Held-for-sale [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Product revenue		51,000
Cost of product revenue		51,000
Expenses
Research and development		401,000
Sales and marketing		11,000
General and administrative		102,000
Total expenses		514,000
Net loss from discontinued operations	$ 0	$ (514,000)

XML 45 R34.htm IDEA: XBRL DOCUMENT

Stockholders' Equity - Additional Information (Detail) - USD ($)	1 Months Ended	3 Months Ended
	Oct. 31, 2015	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense		$ 202,000	$ 359,000
Expected dividend yield		0.00%	0.00%
Weighted average grant date fair value per option granted (in dollars per share)		$ 1.08	$ 1.03
Future stock-based compensation for unvested employee options granted and outstanding		$ 1,500,000
Stock options outstanding, intrinsic value		$ 476,000
Number of shares available for issuance under the plan on the first day of each year		31,776,584		31,755,169
Series D Warrants [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Warrants outstanding (in shares)	256,064
Number of common stock purchased upon issuance of warrants	586,182
Exercise price of warrants (in dollars per share)	$ 12.30
Warrants term	5 years
Warrants expiration date	Oct. 15, 2020
Liquidated damages amount percent of VWAP (percent)	1.00%
Warrants to Purchase Stock [Member] \| 2010 and 2012 Convertible Promissory Notes [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Warrants outstanding (in shares)		102,070
Exercise price of warrants (in dollars per share)		$ 24.35
Warrants term		10 years
Warrants expiration period		2024-11
Underwriter [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Warrants outstanding (in shares)		16,500
Exercise price of warrants (in dollars per share)		$ 35.70
Warrants term		10 years
Warrants expiration period		2024-11
Employee Stock Purchase Plan [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares available for grant		27,967
Percentage of outstanding stock maximum		1.00%
Number of shares available for issuance under the plan on the first day of each year		55,936
Discontinued Operations, Held-for-sale [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense		$ 0	$ 19,000
Minimum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Ownership interest of voting rights of all classes of stock (percent)		10.00%
Stock Options [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period		4 years
Number of shares available for grant		925,749		1,150,961
Income tax benefits recognized from stock-based compensation		$ 0	$ 0
Number of options granted		464,000	616,500
Future stock-based compensation, requisite service period		2 years 10 months 24 days
Stock Options [Member] \| Minimum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of fair market value		110.00%
Stock Options [Member] \| Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Contractual term of option		10 years
ISOs [Member] \| Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Contractual term of option		5 years
Restricted Stock Units [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense		$ 159,000
Stock units granted		0	99,217
Vesting percentage		100.00%

XML 46 R35.htm IDEA: XBRL DOCUMENT

Stockholders' Equity - Summary of Stock Based Compensation Expense (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock compensation expense	$ 202,000	$ 359,000
Continuing Operations [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock compensation expense	202,000	340,000
Research and Development [Member] \| Continuing Operations [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock compensation expense	53,000	105,000
General and Administrative [Member] \| Continuing Operations [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock compensation expense	$ 149,000	$ 235,000

XML 47 R36.htm IDEA: XBRL DOCUMENT

Stockholders' Equity - Schedule of Fair Value of Award Granted Using Black-Scholes Option Pricing Model (Detail)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected life (years)		6 years
Risk-free interest rate	2.60%	2.70%
Volatility	71.00%	70.00%
Dividend rate	0.00%	0.00%
Minimum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected life (years)	6 years
Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected life (years)	6 years 1 month 6 days

XML 48 R37.htm IDEA: XBRL DOCUMENT

Stockholders' Equity - Summary of Stock Option Transactions (Detail) - Stock Options [Member] - $ / shares	3 Months Ended		12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Shares Available for Grant
Options Available, Beginning balance	1,150,961
Options Available, Additional shares authorized	223,742
Options Available, Granted	(464,000)
Options Available, Exercised	0
Options Available, Canceled/Forfeited	15,046
Options Available, Ending balance	925,749		1,150,961
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Beginning balance	1,667,153
Options granted	464,000	616,500
Options exercised	0
Options canceled/forfeited	(15,046)
Ending balance	2,116,107		1,667,153
Options vested at end of period (shares)	901,140
Options vested and expected to vest at end of period (shares)	2,116,107
Weighted-Average Exercise Price per Share
Beginning balance (in dollars per share)	$ 6.03
Options granted (in dollars per share)	1.67
Options exercised (in dollars per share)	0
Options canceled/forfeited (in dollars per share)	8.83
Ending balance (in dollars per share)	5.05		$ 6.03
Options vested at end of period (in dollars per share)	9.14
Options vested and expected to vest at end of period (in dollars per share)	$ 5.05
Weighted Average Remaining Contractual Term
Options outstanding at end of period	8 years 5 months 4 days		8 years 3 months 7 days
Options vested at end of period	7 years 6 months 7 days
Options vested and expected to vest at end of period	8 years 5 months 4 days

XML 49 R38.htm IDEA: XBRL DOCUMENT

Net loss per share - Schedule of Potentially Dilutive Securities Outstanding Excluded from Computations of Diluted Weighted-Average Shares Outstanding (Detail) - shares	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computations of diluted weighted-average shares outstanding	9,962,085	9,599,742
Convertible Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computations of diluted weighted-average shares outstanding		714,200
Underwriter [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computations of diluted weighted-average shares outstanding	16,500	16,500
Series A Warrants to Purchase Shares of Common Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computations of diluted weighted-average shares outstanding	485,121	485,121
Series C Warrant to Purchase Common Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computations of diluted weighted-average shares outstanding	118,083	118,083
Series D Warrant To Purchase Common Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computations of diluted weighted-average shares outstanding	586,162	586,182
2017 PIPE Warrant Liability [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computations of diluted weighted-average shares outstanding	6,024,425	6,024,425
2018 PIPE Warrant Liability [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computations of diluted weighted-average shares outstanding	513,617
Warrants Issued to 2010/2012 Convertible Note Holders to Purchase Common Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computations of diluted weighted-average shares outstanding	102,070	102,070
Options to Purchase Common Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computations of diluted weighted-average shares outstanding	2,116,107	1,551,310
Warrants Issued in 2009 to Purchase Common Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computations of diluted weighted-average shares outstanding		1,851

XML 50 R39.htm IDEA: XBRL DOCUMENT

Fair Value of Contingent Consideration - Additional Information (Detail)			3 Months Ended	10 Months Ended
	Dec. 31, 2017 USD ($)	Mar. 07, 2017 USD ($)	Mar. 31, 2019 USD ($)	Dec. 31, 2017 USD ($)
Asset Acquisition [Line Items]
Fair value of stock consideration		$ 4,200,000
Fair value of cash consideration		1,100,000
Total purchase price consideration		5,300,000
First commercial sales milestone			$ 100,000,000
Second commercial sales milestone			200,000,000
Contingent liability payment on achievement of sales milestone		$ 2,600,000	$ 5,900,000
Changes Measurement [Member]
Asset Acquisition [Line Items]
Fair value of stock consideration	$ 2,700,000
Fair value of cash consideration	2,600,000
Total purchase price consideration	5,300,000
Essentialis, Inc. [Member]
Asset Acquisition [Line Items]
Value of deferred tax liability assumed	$ 1,700,000			$ 1,700,000
Increase (decrease) in valuation allowance				$ (1,700,000)
Essentialis, Inc. [Member] \| Measurement Input, Discount Rate [Member]
Asset Acquisition [Line Items]
Fair value inputs, discount rate (percent)		0.20
Essentialis, Inc. [Member] \| Earnout Payments [Member]
Asset Acquisition [Line Items]
Maximum potential cash earnout payments		$ 30,000,000

XML 51 R40.htm IDEA: XBRL DOCUMENT

Compensation Plan for Board Members - Additional Information (Detail) - shares	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Board of Directors [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Issuance of common stock to board members in lieu of cash payments for quarterly board fees (shares)	21,415	49,519

EXCEL 52 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
XML 53 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 54 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 55 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.1 html 185 218 1 false 56 0 false 5 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://www.soleno.life/20190331/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 100010 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.soleno.life/20190331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.soleno.life/20190331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Condensed Consolidated Statements of Operations (unaudited) Sheet http://www.soleno.life/20190331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited Condensed Consolidated Statements of Operations (unaudited) Statements 4 false false R5.htm 100040 - Statement - Condensed Consolidated Statements of Stockholders' Equity (unaudited) Sheet http://www.soleno.life/20190331/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited Condensed Consolidated Statements of Stockholders' Equity (unaudited) Statements 5 false false R6.htm 100050 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited) Sheet http://www.soleno.life/20190331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (unaudited) Statements 6 false false R7.htm 100060 - Disclosure - Overview Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureOverview Overview Notes 7 false false R8.htm 100070 - Disclosure - Going Concern and Management's Plans Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureGoingConcernAndManagementSPlans Going Concern and Management's Plans Notes 8 false false R9.htm 100080 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 100090 - Disclosure - Fair Value of Financial Instruments Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureFairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 10 false false R11.htm 100100 - Disclosure - Warrant Liabilities Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureWarrantLiabilities Warrant Liabilities Notes 11 false false R12.htm 100110 - Disclosure - Commitments and Contingencies Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 12 false false R13.htm 100120 - Disclosure - CoSense Joint Venture Agreement and Discontinued Operations Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureCosenseJointVentureAgreementAndDiscontinuedOperations CoSense Joint Venture Agreement and Discontinued Operations Notes 13 false false R14.htm 100130 - Disclosure - Stockholders' Equity Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureStockholdersEquity Stockholders' Equity Notes 14 false false R15.htm 100140 - Disclosure - Net loss per share Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureNetLossPerShare Net loss per share Notes 15 false false R16.htm 100150 - Disclosure - Fair Value of Contingent Consideration Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureFairValueOfContingentConsideration Fair Value of Contingent Consideration Notes 16 false false R17.htm 100160 - Disclosure - Compensation Plan for Board Members Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureCompensationPlanForBoardMembers Compensation Plan for Board Members Notes 17 false false R18.htm 100170 - Disclosure - No Subsequent Events Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureNoSubsequentEvents No Subsequent Events Notes 18 false false R19.htm 100180 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.soleno.life/20190331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 19 false false R20.htm 100190 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://www.soleno.life/20190331/taxonomy/role/DisclosureFairValueOfFinancialInstruments 20 false false R21.htm 100200 - Disclosure - Warrant Liabilities (Tables) Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureWarrantLiabilitiesTables Warrant Liabilities (Tables) Tables http://www.soleno.life/20190331/taxonomy/role/DisclosureWarrantLiabilities 21 false false R22.htm 100210 - Disclosure - CoSense Joint Venture Agreement and Discontinued Operations (Tables) Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureCosenseJointVentureAgreementAndDiscontinuedOperationsTables CoSense Joint Venture Agreement and Discontinued Operations (Tables) Tables http://www.soleno.life/20190331/taxonomy/role/DisclosureCosenseJointVentureAgreementAndDiscontinuedOperations 22 false false R23.htm 100220 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureStockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.soleno.life/20190331/taxonomy/role/DisclosureStockholdersEquity 23 false false R24.htm 100230 - Disclosure - Net loss per share (Tables) Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureNetLossPerShareTables Net loss per share (Tables) Tables http://www.soleno.life/20190331/taxonomy/role/DisclosureNetLossPerShare 24 false false R25.htm 100240 - Disclosure - Overview - Additional Information (Detail) Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureOverviewAdditionalInformationDetail Overview - Additional Information (Detail) Details 25 false false R26.htm 100250 - Disclosure - Going Concern and Management's Plans - Additional Information (Detail) Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureGoingConcernAndManagementSPlansAdditionalInformationDetail Going Concern and Management's Plans - Additional Information (Detail) Details 26 false false R27.htm 100260 - Disclosure - Fair Value of Financial Instruments - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Detail) Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail Fair Value of Financial Instruments - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Detail) Details 27 false false R28.htm 100270 - Disclosure - Fair Value of Financial Instruments - Summary of Changes in Fair Value of Level 1 and Level 3 Financial Instruments (Detail) Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfChangesInFairValueOfLevel1AndLevel3FinancialInstrumentsDetail Fair Value of Financial Instruments - Summary of Changes in Fair Value of Level 1 and Level 3 Financial Instruments (Detail) Details 28 false false R29.htm 100280 - Disclosure - Warrant Liabilities - Additional Information (Detail) Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureWarrantLiabilitiesAdditionalInformationDetail Warrant Liabilities - Additional Information (Detail) Details 29 false false R30.htm 100290 - Disclosure - Warrant Liabilities - Fair Value of Convertible Preferred Stock Warrant Liability (Detail) Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureWarrantLiabilitiesFairValueOfConvertiblePreferredStockWarrantLiabilityDetail Warrant Liabilities - Fair Value of Convertible Preferred Stock Warrant Liability (Detail) Details 30 false false R31.htm 100300 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 31 false false R32.htm 100310 - Disclosure - CoSense Joint Venture Agreement and Discontinued Operations - Additional Information (Detail) Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureCosenseJointVentureAgreementAndDiscontinuedOperationsAdditionalInformationDetail CoSense Joint Venture Agreement and Discontinued Operations - Additional Information (Detail) Details 32 false false R33.htm 100320 - Disclosure - CoSense Joint Venture Agreement and Discontinued Operations - Components of Income of Discontinued Operations (Detail) Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureCosenseJointVentureAgreementAndDiscontinuedOperationsComponentsOfIncomeOfDiscontinuedOperationsDetail CoSense Joint Venture Agreement and Discontinued Operations - Components of Income of Discontinued Operations (Detail) Details 33 false false R34.htm 100330 - Disclosure - Stockholders' Equity - Additional Information (Detail) Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail Stockholders' Equity - Additional Information (Detail) Details 34 false false R35.htm 100340 - Disclosure - Stockholders' Equity - Summary of Stock Based Compensation Expense (Detail) Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockBasedCompensationExpenseDetail Stockholders' Equity - Summary of Stock Based Compensation Expense (Detail) Details 35 false false R36.htm 100350 - Disclosure - Stockholders' Equity - Schedule of Fair Value of Award Granted Using Black-Scholes Option Pricing Model (Detail) Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureStockholdersEquityScheduleOfFairValueOfAwardGrantedUsingBlackScholesOptionPricingModelDetail Stockholders' Equity - Schedule of Fair Value of Award Granted Using Black-Scholes Option Pricing Model (Detail) Details 36 false false R37.htm 100360 - Disclosure - Stockholders' Equity - Summary of Stock Option Transactions (Detail) Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionTransactionsDetail Stockholders' Equity - Summary of Stock Option Transactions (Detail) Details 37 false false R38.htm 100370 - Disclosure - Net loss per share - Schedule of Potentially Dilutive Securities Outstanding Excluded from Computations of Diluted Weighted-Average Shares Outstanding (Detail) Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureNetLossPerShareScheduleOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationsOfDilutedWeightedAverageSharesOutstandingDetail Net loss per share - Schedule of Potentially Dilutive Securities Outstanding Excluded from Computations of Diluted Weighted-Average Shares Outstanding (Detail) Details 38 false false R39.htm 100380 - Disclosure - Fair Value of Contingent Consideration - Additional Information (Detail) Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureFairValueOfContingentConsiderationAdditionalInformationDetail Fair Value of Contingent Consideration - Additional Information (Detail) Details 39 false false R40.htm 100390 - Disclosure - Compensation Plan for Board Members - Additional Information (Detail) Sheet http://www.soleno.life/20190331/taxonomy/role/DisclosureCompensationPlanForBoardMembersAdditionalInformationDetail Compensation Plan for Board Members - Additional Information (Detail) Details 40 false false All Reports Book All Reports slno-20190331.xml slno-20190331.xsd slno-20190331_cal.xml slno-20190331_def.xml slno-20190331_lab.xml slno-20190331_pre.xml http://fasb.org/srt/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/us-gaap/2018-01-31 true true ZIP 57 0001564590-19-018686-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-19-018686-xbrl.zip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end